0001193125-21-254146.txt : 20210823 0001193125-21-254146.hdr.sgml : 20210823 20210823172823 ACCESSION NUMBER: 0001193125-21-254146 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 47 CONFORMED PERIOD OF REPORT: 20210630 FILED AS OF DATE: 20210823 DATE AS OF CHANGE: 20210823 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Colonnade Acquisition Corp. II CENTRAL INDEX KEY: 0001837739 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40184 FILM NUMBER: 211197861 BUSINESS ADDRESS: STREET 1: 1400 CENTREPARK BLVD. STREET 2: STE 810 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 BUSINESS PHONE: (561) 712-7860 MAIL ADDRESS: STREET 1: 1400 CENTREPARK BLVD. STREET 2: STE 810 CITY: WEST PALM BEACH STATE: FL ZIP: 33401 10-Q 1 d387099d10q.htm 10-Q 10-Q
falseQ2--12-310001837739FL 0001837739 2021-01-01 2021-06-30 0001837739 2021-06-30 0001837739 2020-12-31 0001837739 2021-04-01 2021-06-30 0001837739 2021-01-01 2021-03-31 0001837739 2021-03-31 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-06-30 0001837739 us-gaap:IPOMember 2021-06-30 0001837739 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-06-30 0001837739 us-gaap:IPOMember claa:PublicWarrantsMember 2021-06-30 0001837739 us-gaap:USTreasurySecuritiesMember 2021-06-30 0001837739 us-gaap:CommonClassAMember 2021-06-30 0001837739 claa:PublicWarrantsMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember 2021-06-30 0001837739 us-gaap:CommonClassBMember 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 claa:PublicWarrantsMember claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember us-gaap:CommonClassAMember 2021-06-30 0001837739 claa:SharePriceMoreThanOrEqualsToUsdEighteenMember us-gaap:CommonClassAMember 2021-06-30 0001837739 claa:SponsorMember srt:MinimumMember 2021-06-30 0001837739 claa:SponsorMember claa:PromissoryNoteMember 2021-06-30 0001837739 claa:SponsorMember 2021-06-30 0001837739 us-gaap:MeasurementInputSharePriceMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 us-gaap:MeasurementInputExercisePriceMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 claa:PostBusinessCombinationTargetCompanyMember 2021-06-30 0001837739 claa:SponsorMember claa:PrivatePlacementWarrantsMember 2021-06-30 0001837739 us-gaap:CommonClassAMember 2020-12-31 0001837739 us-gaap:CommonClassBMember 2020-12-31 0001837739 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001837739 claa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2021-04-01 2021-06-30 0001837739 claa:NonRedeemableOrdinarySharesMember 2021-04-01 2021-06-30 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001837739 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001837739 claa:SponsorMember 2021-04-01 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-04-01 2021-06-30 0001837739 claa:RedeemableCommonClassAMember 2021-04-01 2021-06-30 0001837739 claa:NonredeemableClassaAndClassbSharesMember 2021-04-01 2021-06-30 0001837739 claa:AdministrativeSupportAgreementMember 2021-04-01 2021-06-30 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001837739 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedTermMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputPriceVolatilityMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 us-gaap:IPOMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember claa:MeasurementInputRedemptionTriggerPriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember claa:MeasurementInputRedemptionTriggerPriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 2021-03-12 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputSharePriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:MeasurementInputExercisePriceMember us-gaap:FairValueInputsLevel3Member 2021-03-12 0001837739 us-gaap:IPOMember 2021-03-12 0001837739 us-gaap:IPOMember us-gaap:CommonClassAMember 2021-03-15 2021-03-15 0001837739 us-gaap:IPOMember 2021-01-01 2021-06-30 0001837739 claa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2021-01-01 2021-06-30 0001837739 claa:NonRedeemableOrdinarySharesMember 2021-01-01 2021-06-30 0001837739 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001837739 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001837739 us-gaap:CapitalUnitsMember 2021-01-01 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-01-01 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001837739 claa:SponsorMember 2021-01-01 2021-06-30 0001837739 claa:AffiliateOfSponsorMember claa:AdministrativeSupportAgreementMember 2021-01-01 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2021-01-01 2021-06-30 0001837739 claa:PublicWarrantsMember 2021-01-01 2021-06-30 0001837739 us-gaap:MeasurementInputExpectedTermMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001837739 us-gaap:MeasurementInputPriceVolatilityMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001837739 us-gaap:MeasurementInputRiskFreeInterestRateMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001837739 us-gaap:MeasurementInputExpectedDividendRateMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001837739 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001837739 claa:MeasurementInputRedemptionTriggerPriceMember claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001837739 claa:RedeemableCommonClassAMember 2021-01-01 2021-06-30 0001837739 claa:NonredeemableClassaAndClassbSharesMember 2021-01-01 2021-06-30 0001837739 claa:SponsorMember claa:PrivatePlacementWarrantsMember 2021-01-01 2021-06-30 0001837739 claa:AdministrativeSupportAgreementMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-02-04 2021-02-04 0001837739 claa:SponsorMember claa:PrivatePlacementWarrantsMember 2021-02-04 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-12-31 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-02-24 2021-02-24 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-02-24 0001837739 claa:SponsorMember claa:PromissoryNoteMember 2020-12-17 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-24 2021-03-31 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-24 2021-03-31 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-24 2021-03-31 0001837739 us-gaap:CommonClassAMember 2021-08-23 0001837739 us-gaap:CommonClassBMember 2021-08-23 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001837739 us-gaap:RetainedEarningsMember 2021-03-31 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001837739 us-gaap:RetainedEarningsMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001837739 us-gaap:RetainedEarningsMember 2020-12-31 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-23 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-23 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-11-23 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0001837739 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-03-31 iso4217:USD xbrli:shares xbrli:pure utr:Day utr:Year iso4217:USD xbrli:shares
 
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 10-Q
 
 
(Mark One)
☒
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2021
 
☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from
                    
to
                    
Commission
File No. 001-40184
 
 
COLONNADE ACQUISITION CORP. II
(Exact name of registrant as specified in its charter)
 
 
 
Cayman Islands
  
N/A
(State or other jurisdiction of
incorporation or organization)
  
(I.R.S. Employer
Identification No.)
1400 Centrepark Blvd, Ste 810
West Palm Beach, FL 33401
(Address of Principal Executive Offices, including zip code)
(561) 712-7860
(Registrant’s telephone number, including area code)
N/A
(Former name, former address and former fiscal year, if changed since last report)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class
  
Trading
Symbol(s)
  
Name of each exchange
on which registered
Units, each consisting of one Class A ordinary share, $0.0001 par value,
and one-fifth of
one redeemable warrant
  
CLAA.U
  
The
New York Stock Exchange
Class A ordinary shares, par value $0.0001 par value
  
CLAA
  
The
New York Stock Exchange
Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share
  
CLAA WS
  
The
New York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes
 
 
☒    No  ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of
Regulation S-T (§232.405
of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes
 
 
☒    No  ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer,
a non-accelerated filer,
a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in
Rule 12b-2 of
the Exchange Act.
 
Large accelerated filer   ☐    Accelerated filer   ☐
       
Non-accelerated filer   ☒    Smaller reporting company   ☒
       
         Emerging growth company   ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐
Indicate by check mark whether the registrant is a shell company (as defined in
Rule 12b-2 of
the Exchange Act):    Yes  ☒    No  ☐
As of August
2
3
, 2021, 33,000,000 Class A ordinary shares, par value $0.0001 per share, and 8,250,000 Class B ordinary shares, par value $0.0001 per share, were issued and outstanding, respectively.
 
 
 
COLONNADE ACQUISITION CORP. II
FORM 10-Q FOR
THE QUARTER ENDED JUNE 30, 2021
TABLE OF CONTENTS
 
 
 
 
  
Page
 
  
Item 1.
 
  
 
  
 
3
 
 
  
 
4
 
 
  
 
5
 
 
  
 
6
 
 
  
 
7
 
Item 2.
 
  
 
18
 
Item 3.
 
  
 
22
 
Item 4.
 
  
 
22
 
  
Item 1.
 
  
 
23
 
Item 1A.
 
  
 
23
 
Item 2.
 
  
 
23
 
Item 3.
 
  
 
24
 
Item 4.
 
  
 
24
 
Item 5.
 
  
 
24
 
Item 6.
 
  
 
24
 
  
 
25
 
PART 1 – FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS
COLONNADE ACQUISITION CORP. II
CONDENSED BALANCE SHEETS
 
 
  
June 30,
 
  
 
 
 
  
2021
 
  
December 31,
 
 
  
(Unaudited)
 
  
2020
 
Assets
  
  
Current assets:
  
  
Cash
    $ 529,587      $ 25,000  
Prepaid expenses
      1,164,254        —    
Deferred offering costs associated with IPO
      —          61,814  
    
 
 
     
 
 
  
Total current assets
      1,693,841        86,814  
Cash
and investment
h
eld in
t
rust account
      330,029,692        —    
    
 
 
     
 
 
  
Total assets
    $ 331,723,533      $ 86,814  
    
 
 
     
 
 
  
Liabilities and Shareholders’ Equity
                  
Current liabilities:
                  
Accounts payable and accrued expenses
    $ 65,546      $ 35,000  
Promissory Note – related party
      —          30,000  
    
 
 
     
 
 
  
Total current liabilities
      65,546        65,000  
Warrant Liabilities
      13,368,666        —    
Deferred underwriters’ discount
      10,657,500        —    
    
 
 
     
 
 
  
Total liabilities
      24,091,712        65,000  
    
 
 
     
 
 
  
Commitments
              
Class A ordinary shares subject to possible redemption 30,263,182
 
s
hares at redemption value
      302,631,817        —    
Shareholders’ equity:
                  
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
              
Class A ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 2,736,818
 
s
hares and 0 shares (excluding 30,263,182
 
a
nd 0 shares subject to possible redemption) issued and outstanding at June 30, 2021 and December 31, 2020, respectively
      274        —  
Class B ordinary shares, $0.0001 par value;50,000,000 shares authorized; 8,250,000 and 8,625,000 shares
issued and outstanding at June 30, 2021 and December 31, 2020, respectively
      825        863  
Additional paid-in capital
      1,833,735  
 
      24,137  
Accumulated earnings (deficit)
      3,165,170        (3,186 )
 
    
 
 
     
 
 
  
Total shareholders’ equity
      5,000,004        21,814  
    
 
 
     
 
 
  
Total liabilities and shareholders’ equity
    $ 331,723,533      $ 86,814  
    
 
 
     
 
 
  
See accompanying notes to the financial statements.
 
3
COLONNADE ACQUISITION CORP. II
CONDENSED
STATEMENTS
OF OPERATIONS
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021
(Unaudited)
 
    
For the Three
Months Ended
June 30, 2021
    
For the Six
Months Ended
June 30, 2021
  
Formation and operating costs
    $ 392,887     $ 438,950  
    
 
 
    
 
 
  
Loss from operations
      (392,887 )      (438,950 ) 
    
 
 
    
 
 
  
Other Income (Loss)
                 
Interest income
      24,342       29,692  
Change in fair value of warrant liabilities
      3,502,000       4,052,667  
Offering expenses related to warrant issuance
      —         (475,053 ) 
    
 
 
    
 
 
  
Total other income
      3,526,342       3,607,306  
    
 
 
    
 
 
  
Net income
   
$
3,133,455
 
  
$
3,168,356
 
    
 
 
    
 
 
  
Weighted average shares outstanding, Class A ordinary shares subject to possible redemption
      30,263,182       29,943,752  
    
 
 
    
 
 
  
Basic and diluted net income per share, Class A ordinary shares subject to possible redemption
    $ 0.00     $ 0.00  
    
 
 
    
 
 
  
Weighted average shares
outstanding, Non-redeemable ordinary
shares
      10,986,818       10,268,210  
    
 
 
    
 
 
  
Basic and diluted net loss per
share, Non-redeemable ordinary
shares
    $ 0.28     $ 0.31  
    
 
 
    
 
 
  
See accompanying notes to the financial statements.
 
4
COLONNADE ACQUISITION CORP. II
CONDENSED
STATEMENTS
OF CHANGES IN SHAREHOLDERS’ EQUITY
FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2021
(Unaudited)
 
 
  
Ordinary Shares
 
 
Additional
Paid-In

Capital
 
 
Accumulated
Earnings
(Deficit)
 
 
Total
Shareholders’
Equity
 
 
  
Class A
 
 
Class B
 
 
  
Shares
 
 
Amount
 
 
Shares
 
 
Amount
 
Balance as of December 31, 2020
   
 
—  
 
  
$
—  
 
  
 
8,625,000
 
  
$
863
 
  
$
24,137
 
  
$
(3,186
) 
  
$
21,814
 
Sale of Units in Initial Public Offering, net of underwriter fee
      33,000,000       3,300       —         —         329,996,700       —         330,000,000  
Sale of private placement
      —         —         —         —         8,600,000       —         8,600,000  
Initial fair value of warrants accounted for as liabilities
      —         —         —         —         (17,421,333 )      —         (17,421,333 ) 
Underwriter discount
      —         —         —         —         (6,090,000 )      —         (6,090,000 ) 
Deferred underwriter discount
      —         —         —         —         (10,657,500 )      —         (10,657,500 ) 
Other offering cost charged to shareholders’ equity
      —         —         —         —         (464,569 )      —         (464,569 ) 
Sponsor forfeiture of shares
      —         —         (375,000 )      (38 )      38       —         —    
Reclassification of offering cost related to warrant issuance
      —         —         —         —         475,053    
 
   —         475,053  
Class A ordinary shares subject to possible redemption
      (29,949,836 )   
 
   (2,995 )   
 
   —         —         (299,495,368 )      —         (299,498,363 ) 
Net income
      —         —         —      
 
   —      
 
   —         34,901       34,901  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance as of March 31, 2021
   
 
3,050,164
 
  
$
305
 
  
 
8,250,000
 
  
$
825
 
  
$
4,967,158
 
  
$
31,715
 
  
$
5,000,003
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance as of March 31, 2021
   
 
3,050,164
 
  
$
305
 
  
 
8,250,000
 
  
$
825
 
 
$
4,967,158
 
  
$
31,715
 
  
$
5,000,003
 
Class A ordinary shares subject to possible redemption
      (313,346 )      (31 )      —         —         (3,133,423 )      —         (3,133,454 ) 
Net income
      —         —         —         —         —         3,133,455       3,133,455  
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
Balance as of June 30, 2021
   
 
2,736,818
 
  
$
274
 
  
 
8,250,000
 
  
$
 825
 
  
$
1,833,735
 
  
$
3,165,170
 
  
$
5,000,004
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
    
 
 
  
See accompanying notes to the financial statements.
 
5
COLONNADE ACQUISITION CORP. II
CONDENSED STATEMENT OF CASH FLOWS
FOR THE SIX MONTHS ENDED JUNE 30, 2021
(Unaudited)
 
Cash Flows from Operating Activities:
         
Net income
    $ 3,168,356  
Adjustments to reconcile net income to net cash used in operating activities:
         
Interest earned on trust account
      (29,692 ) 
Change in fair value of warrant liabilities
      (4,052,667 ) 
Offering costs allocated to warrants
      475,053  
Changes in current assets and current liabilities:
      —    
Prepaid assets
      (1,164,254 ) 
Accounts payable
      65,546  
    
 
 
  
Net cash used in operating activities
      (1,537,658 ) 
    
 
 
  
Cash Flows from Investing Activities:
         
Investment of cash into trust account
      (330,000,000 ) 
    
 
 
  
Net cash used in investing activities
      (330,000,000 ) 
    
 
 
  
Cash Flows from Financing Activities:
         
Proceeds from Initial Public Offering, net of underwriters’ discount
      323,910,000  
Proceeds from issuance of Private Placement Warrants
      8,600,000  
Proceeds from issuance of promissory note to related party
      115,824  
Repayment of promissory note to related party
      (145,824 ) 
Payments of offering costs
      (437,755 ) 
    
 
 
  
Net cash provided by financing activities
      332,042,245  
    
 
 
  
Net Change in Cash
      504,587  
Cash - Beginning
      25,000  
    
 
 
  
Cash - Ending
    $ 529,587  
    
 
 
  
Supplemental Disclosure
of Non-cash Financing
Activities:
         
Initial value of Class A ordinary shares subject to possible redemption
    $ 298,977,981  
    
 
 
  
Initial value of warrant liabilities
    $ 17,421,333  
    
 
 
  
Change in value of Class A ordinary shares subject to possible redemption
    $ 3,653,836  
    
 
 
  
Deferred underwriters’ discount payable charged to additional
paid-in
capital
    $ 10,657,500  
    
 
 
  
See accompanying notes to the financial statements.
 
6
COLONNADE ACQUISITION CORP. II
NOTES TO FINANCIAL STATEMENTS
Note 1 — Organization and Business Operations
Organization and General
Colonnade Acquisition Corp. II (the “Company”) was incorporated in Cayman Islands on November 24, 2020. The Company was formed for the purpose of entering into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end.
As of June 30, 2021, the Company had not yet commenced any operations. All activity through June 30, 2021, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will
generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
Financing
The registration statement for the Company’s IPO was declared effective on March 9, 2021 (the “Effective Date”). On March 12, 2021, the Company consummated the IPO of 33,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “public share”), at $10.00 per Unit, generating gross proceeds of $330,000,000, which is discussed in Note 3.
Simultaneously with the closing of the IPO, the Company consummated the sale of 5,733,333 warrants (the “Private Placement Warrant”), at a price of $1.50 per Private Placement Warrant, which is discussed in Note 4.
Transaction costs amounted to $17,212,069 consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs. Of the total transaction cost $475,053 was expensed
as non-operating expenses
in that statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares.
Trust Account
Following the closing of the IPO on March 15, 2021, an amount of $330,000,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of
Rule 2a-7 of
the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its tax obligations, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the trust account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial business combination within 24 months from the closing of the IPO, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.
 
7
Initial Business Combination
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination.
The Company’s business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of taxes payable) at the time of the signing an agreement to enter into a business combination. However, the Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a business combination.
The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The shares of ordinary shares subject to redemption is recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a business combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.
The Company will have until March 12, 2023 (with the ability to extend with shareholder approval) to consummate a business combination (the “Combination Period”). However, if the Company is unable to complete a business combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate.
The Company’s sponsor, Colonnade Sponsor II LLC (the “Sponsor”), officers and directors have agreed to (i) waive their redemption rights with respect to the 7,187,500 Class B ordinary shares issued to the Sponsor for an aggregate purchase price of $25,000 on December 31, 2020 (the “Founder Shares”) and public shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their Founder Shares if the Company fails to complete the initial business combination within the Combination Period.
The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such
 
8
liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Going Concern
As of June 30, 2021, the Company had cash outside the Trust Account of $529,587 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2021, none of the amount in the Trust Account was available to be withdrawn as described above.
Through June 30, 2021, the Company’s liquidity needs were satisfied through rec
e
ipt of $25,000 from the sale of the Founder Shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, it would repay such loaned amounts. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.
The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus
(the “COVID-19 outbreak”). In
March 2020, the WHO
classified the COVID-19 outbreak as
a pandemic, based on the rapid increase in exposure globally. The full impact
of the COVID-19 outbreak continues
to evolve. The impact
of the COVID-19 outbreak on
the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact
of the COVID-19 outbreak on
the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial business combination may be materially adversely affected due to significant governmental measures being implemented to
contain the COVID-19 outbreak or
treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial business combination in a timely manner. The Company’s ability to consummate an initial business combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted
by the COVID-19 outbreak and
the resulting market downturn.
 
9
Note 2— Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X of
the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its IPO as filed with the SEC on March 10, 2021, as well as the Company’s Current Reports on
Form 8-K. The
interim results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
10
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
 
As of
June 30, 2021 and December 31, 2020, the Company had $529,587 and $25,000 in cash, respectively. The Company had no cash equivalents as of
June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
At June 30, 2021, the Trust Account had $330,029,692 held in primarily U.S. Treasury bills. During period January 1, 2021 to June 30, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2021, the Company has not experienced losses on this account.
Ordinary shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021, 30,263,182 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to
the two-class method
of income (loss) per share. Net income per ordinary shares, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account totaling $5,350 for the three months ended June 30, 2021 by the weighted average number of Class A ordinary shares outstanding since original issuance. Net loss per ordinary shares, basic and diluted for Class B ordinary shares is calculated by dividing the net income, adjusted for income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Class B ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.
The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
The basic and diluted loss per ordinary share is calculated as follows:
 
 
  
Three Months
Ended
June 30, 2021
 
  
Six Months
Ended
June 30, 2021
 
Redeemable Class A ordinary shares
  
      
  
      
Numerator: Earnings allocable to Redeemable Class A ordinary shares
  
      
  
      
Interest earned on marketable securities held in Trust Account
  
$
24,342
 
  
$
29,692
 
Less: Company portion available to pay taxes
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Net income allocable to shares subject to possible redemption
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Denominator: Weighted Average Redeemable Class A ordinary shares
  
      
  
      
Basic and diluted weighted average shares outstanding
  
 
30,263,182
 
  
 
29,943,752
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
Class A and Class B ordinary shares
  
      
  
      
Numerator: Net Income Minus Net Earnings
  
      
  
      
Net income
  
$
3,133,455
 
  
$
3,168,356
 
Less: Income allocable to ordinary shares subject to possible redemption
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
net income
  
$
3,109,113
 
  
$
3,138,664
 
 
  
 
 
 
  
 
 
 
Weighted average shares outstanding, basic and diluted
  
 
10,986,818
 
  
 
10,268,210
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
0.28
 
  
$
0.31
 
 
  
 
 
 
  
 
 
Offering Costs
The Company complies with the requirements of the
ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $17,212,069 have been charged to shareholders’ equity (consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs). Of the total transaction cost $475,053 was reclassed to expense as
a non-operating expense
in the statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares.
 
11
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Accounting Standards
Codification 815-40, Derivatives
and Hedging; Contracts in Entity’s Own Equity (“ASC 815
”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.
The Company accounts for its 12,333,333 warrants issued in connection with its IPO (6,600,000) and private placement (5,733,333) as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the IPO and private placement has been estimated using Monte-Carlo simulations at each measurement date.
Income Taxes
The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
Note 3 — Initial Public Offering
Pursuant to the IPO, the Company sold 33,000,000 Units, (at a price of $10.00 per Unit. Each Unit consists of one share of Class A ordinary shares, par value $0.0001 per
share one-fifth of
one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share.
 
12
Note 4 — Private Placement Warrants
Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,733,333 Private Placement Warrants at a price of $1.50 per warrant ($8,600,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account.
The Private Placement Warrants will be identical to the warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to certain registration rights.
If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO.
The Sponsor has agreed to (i) waive its redemption rights with respect to its Founder Shares and public shares in connection with the completion of the initial Business Combination, (ii) waive its redemption rights with respect to its Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights
or pre-initial Business
Combination activity, (iii) waive its rights to liquidating distributions from the Trust Account with respect to its Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any Founder Shares held by the Sponsor and any public shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.
Note 5 — Related Party Transactions
Founder Shares
On December 31, 2020, the Company issued 7,187,500 Class B ordinary shares to the Sponsor for an aggregate purchase price of $25,000. On February 24, 2021, the Company effected a share capitalization of 1,437,500 shares, resulting in 8,625,000 shares of Class B ordinary shares being issued and outstanding. Up to 1,125,000 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On March 12, 2021, the underwriter partially exercised the over-allotment option and therefore 375,000 Founder Shares were forfeited, and 750,000 Founder Shares are no longer subject to forfeiture, resulting in 8,250,000 Founder Shares outstanding at June 30, 2021.
The initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances
(the “lock-up”).
Notwithstanding the foregoing, if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for
share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released
from
the lock-up.
 
13
Promissory Note — Related Party
On December 17, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans
are non-interest bearing,
unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the offering proceeds that has been allocated to the payment of offering expenses. As of June 30, 2021, there was no outstanding balance under the promissory note.
Administrative Support Agreement
Commencing on the date of the IPO, the Company has agreed to pay the Sponsor a total of $30,000 per month for office space and administrative support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
 
For the three and six month periods ended June 30, 2021, the Company has incurred $111,290 
in expense pursuant to this agreement. All outstanding fees owed are paid and thus nothing is accrued as of June 30, 2021.
Working Capital Loans
In addition,
in
 
order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of
June 30
,
2021, the Company had not outstanding borrowings under the Working Capital Loans.
Note 6 — Commitments & Contingencies
Registration Rights
The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants which will be issued in a private placement simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriters Agreement
On March 12, 2021, the Company paid a fixed underwriting discount of $6,090,000. Additionally, a deferred underwriting discount of $10,657,500 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.
 
14
Note 7 — Shareholders’ Equity
Preference shares
 — The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. At June 30, 2021, there were no shares of preference shares issued or outstanding.
Class
 A ordinary shares
 — The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 2,736,818 and 0 shares issued and outstanding (excluding 30,263,182 and 0 shares subject to possible redemption), respectively
Class
 B ordinary shares
 — The Company is authorized to issue a total of 50,000,000 Class B ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 8,250,000 and 8,625,000 shares of Class B ordinary shares issued or outstanding, respectively.
Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders.
The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on
a one-for-one basis,
subject to adjustment for
share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity- linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less
than one-for-one basis.
Note 8 — Warrants
Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Sponsor or its affiliate, without taking into account any Founder Shares held by the Sponsor or such affiliate, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, the $18.00 per share redemption trigger prices described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
 
15
The warrants will become exercisable 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, or earlier upon redemption or liquidation.
The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement o, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon not less than 30 days’ prior written notice of redemption to each warrant holder
(the “30-day redemption
period”); and
 
  •  
if, and only if, the reported sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within
a 30-trading day
period ending three business days before the Company sends to the notice of redemption to the warrant holders.
In no event will the Company be required to net cash settle any warrants.
Redemption of Warrants when the price per Class
 A Ordinary Share equals or exceeds $10.00.
 The Company may also redeem the outstanding Public Warrants once they become exercisable:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.10 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption;
 provided
 that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; and
 
  •  
if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within
a 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders.
If the Company is unable to complete the initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
 
16
Note 9 — Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. Contracts in Entity’s Own Equity (“ASC 815”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
•
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
 
•
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
•
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
 
  
 
 
  
Quoted
 
  
Significant
 
  
Significant
 
  
 
 
  
Prices In
 
  
Other
 
  
Other
 
  
 
 
  
Active
 
  
Observable
 
  
Unobservable
 
  
June 30,
 
  
Markets
 
  
Inputs
 
  
Inputs
 
  
2021
 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Description
                                    
Warrant liabilities – Public Warrants
      7,062,000        7,062,000        —          —    
Warrant liabilities – Private Warrants
      6,306,667        —          —          6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
     $ 13,368,667      $  7,062,000      $  —        $ 6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The Company utilizes a Black Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S.
Treasury zero-coupon yield
curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate,
which the Company anticipates to remain at zero.
The aforementioned warrant liabilities are not subject to qualified hedge accounting.
There were
no
transfers between Levels 1, 2 or 3 during the quarter ended
 
June 30, 2021.
 
17
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
At

March 12,

2021

(Initial

Measurement)

Public

Warrants
    
At

March 12,

2021

(Initial

Measurement)

Private

Placement

Warrants
  
                                             
Share price
   
$
9.70
 
  
$
9.70
 
Strike price
   
$
11.50
 
  
$
11.50
 
Term (in years)
   
 
5.0
 
  
 
5.0
 
Volatility
   
 
24.0
% 
  
 
24.0
% 
Risk-free rate
   
 
0.98
% 
  
 
0.98
% 
Dividend yield
   
 
0.0
% 
  
 
0.0
% 
Redemption trigger price
   
$
18.00
 
  
$
0.00
 

     
                  
  
   
At

June 30,

2021

Private

Placement

Warrants
  
                          
Share price
  
$
9.77
 
Strike price
  
$
11.50
 
Term (in years)
  
 
5.0
 
Volatility
  
 
19.2
% 
Risk-free rate
  
 
0.94
% 
Dividend yield
  
 
0.0
% 
Redemption trigger price
  
$
0.00
 
The following table presents the changes in the fair value of warrant liabilities:
 
 
  
Public
 
  
Private
 
  
Warrant
 
  
Placement
 
  
Liabilities
 
Fair value as of November 24, 2020
    $ —        $ —        $ —    
Initial measurement on March 12, 2021
      9,108,000        8,313,333        17,421,333  
Change in valuation inputs or other assumptions
  
 
(264,001
) 
     
(286,666
) 
     
(550,667
)
Fair value as of March 31, 2021
  
$
8,844,000
      $
8,026,667
      $
16,870,667
 
Change in valuation inputs or other assumptions
      (1,782,000 )       (1,720,000 )       (3,502,000 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2021
    $ 7,062,000      $ 6,306,667      $ 13,368,667  
    
 
 
     
 
 
     
 
 
  
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
References in this report (the “Quarterly Report”) to “we,” “us” or the “Company” refer to Colonnade Acquisition Corp. II References to our “management” or our “management team” refer to our officers and directors, and references to the “Sponsor” refer to Colonnade Sponsor II LLC. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere in this Quarterly Report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.
 
18
Special Note Regarding Forward-Looking Statements
This Quarterly Report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act that are not historical facts and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. All statements, other than statements of historical fact included in this Quarterly Report including, without limitation, statements in this “Management’s Discussion and Analysis of Financial Condition and Results of Operations” regarding the Company’s financial position, business strategy and the plans and objectives of management for future operations, are forward-looking statements. Words such as “expect,” “believe,” “anticipate,” “intend,” “estimate,” “seek” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements relate to future events or future performance, but reflect management’s current beliefs, based on information currently available. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. For information identifying important factors that could cause actual results to differ materially from those anticipated in the forward-looking statements, please refer to the Risk Factors section of this Quarterly Report and the Risk Factors section of the Registration Statements on
Form S-1 (Registration No. 333-253091) filed
with the SEC. The Company’s securities filings can be accessed on the EDGAR section of the SEC’s website at www.sec.gov. Except as expressly required by applicable securities law, the Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.
Overview
We are a blank check company incorporated in the Cayman Islands on November 24, 2020 formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses. We intend to effectuate our Business Combination using cash derived from the proceeds of the IPO, our shares, debt or a combination of cash, shares and debt.
We expect to continue to incur significant costs in the pursuit of our acquisition plans. We cannot assure you that our plans to complete a Business Combination will be successful.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date. Our only activities from November 24, 2020 (inception) through June 30, 2021 were organizational activities, those necessary to prepare for the IPO, described below, and the Company’s search for a target business with which to complete a Business Combination. We do not expect to generate any operating revenues until after the completion of our initial Business Combination. We
generate non-operating income
in the form of interest income on marketable securities. We are incurring expenses as a result of being a public company (for legal, financial reporting, accounting and auditing compliance), as well as for due diligence expenses in connection with completing a Business Combination.
For the six months ended, we had a net income of $3,168,356. We incurred $438,950 of formation and operating costs consisting mostly of general and administrative expenses. We had investment income of $29,692 on our amounts held in the Trust Account.
For the three months ended, we had a net income of $3,133,455. We incurred $392,887 of formation and operating costs consisting mostly of general and administrative expenses. We had investment income of $24,342 on our amounts held in the Trust Account.
 
19
Liquidity, Capital Resources and Going Concern
Until the consummation of the IPO, the Company’s only source of liquidity was an initial purchase of ordinary shares by the Sponsor and loans from our Sponsor.
On March 12, 2021, we consummated the IPO of 33,000,000 Units, at a price of $10.00 per Unit, generating gross proceeds of $330,000,000. Simultaneously with the closing of the IPO, we consummated the sale of 5,733,333 Private Placement Warrants to the Sponsor at a price of $1.50 per warrant, generating gross proceeds of $8,600,000.
Following the IPO, and the sale of the Private Placement Warrants, a total of $330,000,000 was placed in the Trust Account. We incurred $17,212,069 in transaction costs, including $6,090,000 of underwriting fees, $10,657,500 of deferred underwriting fees and $464,569 of other costs.
For the six months ended June 30, 2021, cash used in operating activities was $1,537,658, which consisted of our net income of $3,168,356, interest earned on marketable securities held in the Trust Account of $29,692, changes in the fair value of warrant liabilities of $4,052,667, offering costs allocated to warrants of $475,053 and changes in current assets and current liabilities, which used $1,537,658 of cash.
As of June 30, 2021, we had cash and marketable securities held in the Trust Account of $330,029,692. We may withdraw interest to pay our taxes, if any. Through June 30, 2021, we have not withdrawn any amounts to pay for our tax obligations. We intend to use substantially all of the funds held in the Trust Account, including any amounts representing interest earned on the Trust Account (which interest shall be net of taxes payable) to complete our Business Combination. To the extent that our share capital is used, in whole or in part, as consideration to complete a Business Combination, the remaining proceeds held in the Trust Account will be used as working capital to finance the operations of the target business or businesses, make other acquisitions and pursue our growth strategies.
As of June 30, 2021, we had cash outside the trust account of $529,587 available for working capital needs. All remaining cash held in the trust account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a business combination or to redeem ordinary shares. As of June 30, 2021, none of the amount in the trust account was available to be withdrawn as described above.
Through June 30, 2021, the Company’s liquidity needs were satisfied through receipt of $25,000 from the sale of the Founder Shares, and the remaining net proceeds from the IPO and the sale of Private Placement Warrants.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, our Sponsor or an affiliate of our Sponsor or certain of our officers and directors may, but are not obligated to, loan us funds as may be required. If we complete a Business Combination, we would repay such loaned amounts. In the event that a Business Combination does not close, we may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from our Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.
The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
 
20
Off-Balance Sheet
Financing Arrangements
We have no obligations, assets or liabilities, which would be
considered off-balance sheet
arrangements as of June 30, 2021. We do not participate in transactions that create relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of
facilitating off-balance sheet
arrangements. We have not entered into
any off-balance sheet
financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased
any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease obligations or long-term liabilities, other than an agreement to pay the Sponsor a monthly fee of $30,000 for office space, utilities, secretarial and administrative support services, provided to the Company. We began incurring these fees on March 10, 2021 and will continue to incur these fees monthly until the earlier of the completion of a Business Combination and the Company’s liquidation.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or $10,657,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.
Critical Accounting Policies
The preparation of condensed financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements, and income and expenses during the periods reported. Actual results could materially differ from those estimates. We have identified the following critical accounting policies:
Class A Ordinary Shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s Class A ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s condensed balance sheet.
Net Income (Loss) Per Ordinary Share
We apply
the two-class method
in calculating earnings per share. Ordinary shares subject to possible redemption, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per ordinary share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings. Our net income is adjusted for the portion of income that is attributable to ordinary shares subject to redemption, as these shares only participate in the earnings of the Trust Account and not our income or losses.
 
21
Recent Accounting Standards
Management does not believe that any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.
Warrant Liabilities
We account for the warrants issued in connection with the Initial Public Offering in accordance with ASC 815, under which the warrants do not meet the criteria for equity classification and must be recorded as liabilities. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants are measured at fair value at inception and at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the Statement of Operations in the period of change.
Derivative Warrant Liabilities
We do not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. We evaluate all of our financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and
ASC 815-15. The
classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is reassessed at the end of each reporting period.
We issued an aggregate of 12,333,333 warrants in connection with our IPO and private placement, which, as a result of the revision described in Note 2 “Correction of An Error In Previously Furnished Financial Statements” to the financial statements included herein, are recognized as derivative liabilities in accordance with ASC 815. Accordingly, we recognize the warrants as liabilities at fair value and adjust the instruments to fair value at each reporting period. The liabilities are subject to remeasurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s statement of operations. The fair value of Public Warrants have been estimated using Monte Carlo simulations and the Private Placement Warrants have been estimated using Black Scholes model at each measurement date.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
We are a smaller reporting company as defined by
Rule 12b-2 of
the Exchange Act and are not required to provide the information otherwise required under this item.
ITEM 4. CONTROLS AND PROCEDURES
Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to our management, including our Chief Executive Officer, to allow timely decisions regarding required disclosure.
Evaluation of Disclosure Controls and Procedures
As required by Rules
13a-15
and
15d-15
under the Exchange Act, our Chief Executive Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of June 30, 2021. Based upon his evaluation, our Chief Executive Officer concluded that our disclosure controls and procedures (as defined in Rules
13a-15(e)
and
15d-15(e)
under the Exchange Act) were not effective as of June 30, 2021, due solely to the material weakness in our internal control over financial reporting regarding the classification of the Company’s warrants as components of equity instead of as derivative liabilities, which was identified and discussed in Part I, Item 4 of our Form
10-Q
for the period ended March 31, 2021 filed with the SEC on May 27, 2021. In light
 
22
of this material weakness, we performed additional analysis as deemed necessary to ensure that our financial statements were prepared in accordance with GAAP. Accordingly, notwithstanding the identified material weakness as of June 30, 2021, management, including our Chief Executive Officer, believes that the financial statements included in this Quarterly Report on
Form 10-Q
present fairly in all material respects our financial position, results of operations and cash flows for the period presented in conformity with GAAP.
We do not expect that our disclosure controls and procedures will prevent all errors and all instances of fraud. Disclosure controls and procedures, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the disclosure controls and procedures are met. Further, the design of disclosure controls and procedures must reflect the fact that there are resource constraints, and the benefits must be considered relative to their costs. Because of the inherent limitations in all disclosure controls and procedures, no evaluation of disclosure controls and procedures can provide absolute assurance that we have detected all our control deficiencies and instances of fraud, if any. The design of disclosure controls and procedures also is based partly on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions.
Changes in Internal Control Over Financial Reporting
We have commenced our remediation efforts in connection with the identification of the material weakness discussed above and have taken the following steps during the quarter ended June 30, 2021:
 
  •  
We have implemented procedures intended to ensure that we identify and apply the applicable accounting guidance to all complex transactions.
 
  •  
We are establishing additional monitoring and oversight controls designed to ensure the accuracy and completeness of our consolidated financial statements and related disclosures.
While we took considerable action to remediate the material weakness, such remediation has not been fully evidenced. Accordingly, we continue to test our controls implemented in the second quarter to assess whether our controls are operating effectively. While there can be no assurance, we believe our material weakness will be remediated during the course of fiscal 2021.
Other than the changes discussed above, there have been no changes to our internal control over financial reporting during the quarter ended June 30, 2021 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
PART II—OTHER INFORMATION
ITEM 1. LEGAL PROCEEDINGS.
None.
ITEM 1A. RISK FACTORS.
As of the date of this Quarterly Report, there have been no material changes with respect to those risk factors previously disclosed in our Registration Statement filed with the SEC and in our Form
10-Q
for the period ended March 31, 2021 filed with the SEC. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
On March 12, 2021, we consummated the IPO of 33,000,000 Units. The Units sold in the IPO were sold at an offering price of $10.00 per unit, generating total gross proceeds of $330,000,000. Barclays Capital Inc. and Deutsche Bank Securities Inc. acted as the joint-book running managers of the IPO. The securities in the offering were registered under the Securities Act on a registration statement on
Form S-1 (No. 333-253091). The
Securities and Exchange Commission declared the registration statement effective on March 9, 2021.
 
23
Simultaneously with the consummation of the IPO, the Sponsor consummated the private placement of an aggregate of 5,733,333 warrants at a price of $1.50 per Private Placement Warrant, generating total proceeds of $8,600,000. The issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
The Private Placement Warrants are identical to the warrants underlying the Units sold in the IPO, except that the Private Placement Warrants are not transferable, assignable or salable until 30 days after the completion of a Business Combination, subject to certain limited exceptions.
Of the gross proceeds received from the IPO and the Private Placement Warrants, $330,000,000 was placed in the Trust Account.
We paid a total of $6,090,000 in underwriting discounts and commissions and $464,569 for other costs and expenses related to the IPO. In addition, the underwriters agreed to defer up to $10,657,500 in underwriting discounts and commissions.
For a description of the use of the proceeds generated in our IPO, see Part I, Item 2 of this
Form 10-Q.
ITEM 3. DEFAULTS UPON SENIOR SECURITIES.
None.
ITEM 4. MINE SAFETY DISCLOSURES.
Not applicable.
ITEM 5. OTHER INFORMATION.
None.
ITEM 6. EXHIBITS.
The following exhibits are filed as part of, or incorporated by reference into, this Quarterly Report on
Form 10-Q.
 
No.
   
Description of Exhibit
  31.1*    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a) and 15(d)-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
  32.1**    Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*    Inline XBRL Instance Document (the instance document does not appear in the interactive Data File because its XBRL tags are embedded within the Inline XBRL document)
101.CAL*    Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.SCH*    Inline XBRL Taxonomy Extension Schema Document
101.DEF*    Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*    Inline XBRL Taxonomy Extension Labels Linkbase Document
101.PRE*    Inline XBRL Taxonomy Extension Presentation Linkbase Document
104    Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
 
*
Filed herewith.
**
This certification is furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
24
SIGNATURES
Pursuant to the requirements of Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
   
COLONNADE ACQUISITION CORP. II
Date: August 23, 2021    
/s/ Remy W. Trafelet
    Name:   Remy W. Trafelet
    Title:   Chief Executive Officer and Director
     
(Principal Executive Officer and Principal
Financial and Accounting Officer)
 
25
EX-31.1 2 d387099dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A–14(A)

UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Remy W. Trafelet, certify that:

 

  1.

I have reviewed this Quarterly Report on Form 10-Q of Colonnade Acquisition Corp. II;

 

  2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

  3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

  4.

I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

 

  a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under my supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this report is being prepared;

 

  b)

(Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313);

 

  c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report my conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

  d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

  5.

I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

  (b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: August 23, 2021     By:  

/s/ Remy W. Trafelet

      Remy W. Trafelet
      Chief Executive Officer and Director
      (Principal Executive Officer and Principal Financial and Accounting Officer)
 EX-32.1 3 d387099dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADDED BY

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Colonnade Acquisition Corp. II (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2021, as filed with the Securities and Exchange Commission (the “Report”), I, Remy W. Trafelet, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. §1350, as added by §906 of the Sarbanes-Oxley Act of 2002, that:

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2. To my knowledge, the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

 

Date: August 23, 2021     By:  

/s/ Remy W. Trafelet

      Remy W. Trafelet
      Chief Executive Officer and Director
      (Principal Executive Officer and Principal Financial and Accounting Officer)
 EX-101.SCH 4 claa-20210630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements of Changes in Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Private Placement Warrants link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Shareholders' Equity link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Warrants link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Fair Value Measurements link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Significant Accounting Policies (Tables) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details) link:presentationLink link:definitionLink link:calculationLink 1023 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1024 - Disclosure - Private Placement Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1025 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1026 - Disclosure - Commitments & Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1027 - Disclosure - Shareholders' Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1028 - Disclosure - Warrants - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1029 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) link:presentationLink link:definitionLink link:calculationLink 1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) link:presentationLink link:definitionLink link:calculationLink 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail) link:presentationLink link:definitionLink link:calculationLink 1032 - Disclosure - Fair Value Measurements - Additional Information (Details) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 5 claa-20210630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 6 claa-20210630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 claa-20210630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE EX-101.PRE 8 claa-20210630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 9 d387099d10q_htm.xml IDEA: XBRL DOCUMENT 0001837739 2021-01-01 2021-06-30 0001837739 2021-06-30 0001837739 2020-12-31 0001837739 2021-04-01 2021-06-30 0001837739 2021-01-01 2021-03-31 0001837739 2021-03-31 0001837739 claa:PublicWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PrivateWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:IPOMember 2021-06-30 0001837739 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:IPOMember 2021-06-30 0001837739 us-gaap:USTreasurySecuritiesMember 2021-06-30 0001837739 us-gaap:CommonClassAMember 2021-06-30 0001837739 claa:PublicWarrantsMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember 2021-06-30 0001837739 us-gaap:CommonClassBMember 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 claa:PublicWarrantsMember claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 us-gaap:CommonClassAMember claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 us-gaap:CommonClassAMember claa:SharePriceMoreThanOrEqualsToUsdEighteenMember 2021-06-30 0001837739 srt:MinimumMember claa:SponsorMember 2021-06-30 0001837739 claa:PromissoryNoteMember claa:SponsorMember 2021-06-30 0001837739 claa:SponsorMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-06-30 0001837739 claa:PostBusinessCombinationTargetCompanyMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-06-30 0001837739 us-gaap:CommonClassAMember 2020-12-31 0001837739 us-gaap:CommonClassBMember 2020-12-31 0001837739 us-gaap:CommonClassAMember 2021-04-01 2021-06-30 0001837739 claa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2021-04-01 2021-06-30 0001837739 claa:NonRedeemableOrdinarySharesMember 2021-04-01 2021-06-30 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001837739 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001837739 claa:SponsorMember 2021-04-01 2021-06-30 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-04-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-04-01 2021-06-30 0001837739 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-04-01 2021-06-30 0001837739 claa:RedeemableCommonClassAMember 2021-04-01 2021-06-30 0001837739 claa:NonredeemableClassaAndClassbSharesMember 2021-04-01 2021-06-30 0001837739 claa:AdministrativeSupportAgreementMember 2021-04-01 2021-06-30 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001837739 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-03-12 2021-03-12 0001837739 us-gaap:IPOMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-03-12 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member claa:MeasurementInputRedemptionTriggerPriceMember 2021-03-12 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member claa:MeasurementInputRedemptionTriggerPriceMember 2021-03-12 2021-03-12 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputSharePriceMember 2021-03-12 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-03-12 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExercisePriceMember 2021-03-12 0001837739 us-gaap:IPOMember 2021-03-12 0001837739 us-gaap:CommonClassAMember us-gaap:IPOMember 2021-03-15 2021-03-15 0001837739 us-gaap:IPOMember 2021-01-01 2021-06-30 0001837739 claa:ClassAOrdinarySharesSubjectToPossibleRedemptionMember 2021-01-01 2021-06-30 0001837739 claa:NonRedeemableOrdinarySharesMember 2021-01-01 2021-06-30 0001837739 us-gaap:CommonClassAMember 2021-01-01 2021-06-30 0001837739 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001837739 us-gaap:CapitalUnitsMember 2021-01-01 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-01-01 2021-06-30 0001837739 us-gaap:CommonClassAMember claa:SharePriceLessThanOrEqualsToUsdEighteenMember 2021-01-01 2021-06-30 0001837739 claa:SponsorMember 2021-01-01 2021-06-30 0001837739 claa:AdministrativeSupportAgreementMember claa:AffiliateOfSponsorMember 2021-01-01 2021-06-30 0001837739 claa:SharePriceLessThanOrEqualsToUsdNinePointTwoMember 2021-01-01 2021-06-30 0001837739 claa:PublicWarrantsMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedTermMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember 2021-01-01 2021-06-30 0001837739 us-gaap:CommonClassBMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member claa:MeasurementInputRedemptionTriggerPriceMember 2021-01-01 2021-06-30 0001837739 claa:RedeemableCommonClassAMember 2021-01-01 2021-06-30 0001837739 claa:NonredeemableClassaAndClassbSharesMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-01-01 2021-06-30 0001837739 claa:AdministrativeSupportAgreementMember 2021-01-01 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-02-04 2021-02-04 0001837739 claa:PrivatePlacementWarrantsMember claa:SponsorMember 2021-02-04 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2020-01-01 2020-12-31 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-02-24 2021-02-24 0001837739 claa:SponsorMember us-gaap:CommonClassBMember 2021-02-24 0001837739 claa:PromissoryNoteMember claa:SponsorMember 2020-12-17 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-24 2021-03-31 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-24 2021-03-31 0001837739 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-24 2021-03-31 0001837739 us-gaap:CommonClassAMember 2021-08-23 0001837739 us-gaap:CommonClassBMember 2021-08-23 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-03-31 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-03-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001837739 us-gaap:RetainedEarningsMember 2021-03-31 0001837739 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2021-06-30 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2021-06-30 0001837739 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001837739 us-gaap:RetainedEarningsMember 2021-06-30 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-06-30 0001837739 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2020-12-31 0001837739 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001837739 us-gaap:RetainedEarningsMember 2020-12-31 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-23 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-23 0001837739 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-11-23 0001837739 claa:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001837739 claa:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 0001837739 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-03-31 iso4217:USD shares pure utr:Day utr:Year iso4217:USD shares false Q2 --12-31 0001837739 FL 10-Q true 2021-06-30 2021 false 001-40184 COLONNADE ACQUISITION CORP. II E9 1400 Centrepark Blvd Ste 810 West Palm Beach 33401 561 712-7860 Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant CLAA.U NYSE Class A ordinary shares, par value $0.0001 par value CLAA NYSE Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share CLAA WS NYSE Yes Yes Non-accelerated Filer true true false true 33000000 8250000 529587 25000 1164254 61814 1693841 86814 330029692 331723533 86814 65546 35000 30000 65546 65000 13368666 10657500 24091712 65000 30263182 302631817 0.0001 0.0001 5000000 5000000 0 0 0 0 0.0001 0.0001 500000000 500000000 2736818 2736818 0 0 30263182 0 274 0 0.0001 0.0001 50000000 50000000 8250000 8250000 8625000 8625000 825 863 1833735 24137 3165170 -3186 5000004 21814 331723533 86814 392887 438950 -392887 -438950 24342 29692 -3502000 -4052667 0 475053 3526342 3607306 3133455 3168356 30263182 29943752 0.00 0.00 10986818 10268210 0.28 0.31 8625000 863 24137 -3186 21814 33000000 3300 329996700 330000000 8600000 8600000 -17421333 -17421333 -6090000 -6090000 -10657500 -10657500 -464569 -464569 375000 38 -38 475053 475053 29949836 -2995 -299495368 -299498363 34901 34901 3050164 305 8250000 825 4967158 31715 5000003 3050164 305 8250000 825 4967158 31715 5000003 -313346 -31 -3133423 -3133454 3133455 3133455 2736818 274 8250000 825 1833735 3165170 5000004 3168356 29692 -4052667 475053 1164254 65546 -1537658 330000000 -330000000 323910000 8600000 115824 145824 437755 332042245 504587 25000 529587 298977981 17421333 3653836 10657500 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 1 — Organization and Business Operations </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Organization and General </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Colonnade Acquisition Corp. II (the “Company”) was incorporated in Cayman Islands on November 24, 2020. The Company was formed for the purpose of entering into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2021, the Company had not yet commenced any operations. All activity through June 30, 2021, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">generate non-operating income</div> in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financing </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The registration statement for the Company’s IPO was declared effective on March 9, 2021 (the “Effective Date”). On March 12, 2021, the Company consummated the IPO of 33,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “public share”), at $10.00 per Unit, generating gross proceeds of $330,000,000, which is discussed in Note 3. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the IPO, the Company consummated the sale of 5,733,333 warrants (the “Private Placement Warrant”), at a price of $1.50 per Private Placement Warrant, which is discussed in Note 4. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Transaction costs amounted to $17,212,069 consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs. Of the total transaction cost $475,053 was expensed <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">as non-operating expenses</div> in that statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares. </div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Trust Account </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Following the closing of the IPO on March 15, 2021, an amount of $330,000,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Rule 2a-7 of</div> the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its tax obligations, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the trust account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial business combination within 24 months from the closing of the IPO, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders. </div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial Business Combination </div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of taxes payable) at the time of the signing an agreement to enter into a business combination. However, the Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a business combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The shares of ordinary shares subject to redemption is recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a business combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company will have until March 12, 2023 (with the ability to extend with shareholder approval) to consummate a business combination (the “Combination Period”). However, if the Company is unable to complete a business combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s sponsor, Colonnade Sponsor II LLC (the “Sponsor”), officers and directors have agreed to (i) waive their redemption rights with respect to the 7,187,500 Class B ordinary shares issued to the Sponsor for an aggregate purchase price of $25,000 on December 31, 2020 (the “Founder Shares”) and public shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their Founder Shares if the Company fails to complete the initial business combination within the Combination Period. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such </div></div><div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;;display:inline;">Going Concern</div> </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2021, the Company had cash outside the Trust Account of $529,587 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2021, none of the amount in the Trust Account was available to be withdrawn as described above. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Through June 30, 2021, the Company’s liquidity needs were satisfied through rec<div style="display:inline;">e</div>ipt of $25,000 from the sale of the Founder Shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, it would repay such loaned amounts. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risks and Uncertainties </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(the “COVID-19 outbreak”). In</div> March 2020, the WHO <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">classified the COVID-19 outbreak as</div> a pandemic, based on the rapid increase in exposure globally. The full impact <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the COVID-19 outbreak continues</div> to evolve. The impact <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the COVID-19 outbreak on</div> the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">of the COVID-19 outbreak on</div> the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial business combination may be materially adversely affected due to significant governmental measures being implemented to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">contain the COVID-19 outbreak or</div> treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial business combination in a timely manner. The Company’s ability to consummate an initial business combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">by the COVID-19 outbreak and</div> the resulting market downturn. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 33000000 10.00 330000000 5733333 1.50 17212069 6090000 10657500 464569 475053 330000000 P185D 0.80 0.50 10.00 5000001 1 529587 25000 1500000 1.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 2— Significant Accounting Policies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-Q and</div> Article 8 of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Regulation S-X of</div> the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its IPO as filed with the SEC on March 10, 2021, as well as the Company’s Current Reports on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 8-K. The</div> interim results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company Status </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to non-emerging growth</div> companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of<br/> June 30, 2021 and December 31, 2020, the Company had $529,587 and $25,000 in cash, respectively. The Company had no cash equivalents as of<br/> June 30, 2021 and December 31, 2020.</div> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable Securities Held in Trust Account </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021, the Trust Account had $330,029,692 held in primarily U.S. Treasury bills. During period January 1, 2021 to June 30, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2021, the Company has not experienced losses on this account. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ordinary shares Subject to Possible Redemption </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021, 30,263,182 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Common Share </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the two-class method</div> of income (loss) per share. Net income per ordinary shares, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account totaling $5,350 for the three months ended June 30, 2021 by the weighted average number of Class A ordinary shares outstanding since original issuance. Net loss per ordinary shares, basic and diluted for Class B ordinary shares is calculated by dividing the net income, adjusted for income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Class B ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The basic and diluted loss per ordinary share is calculated as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Class A ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Earnings allocable to Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company portion available to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30,263,182</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,943,752</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Class A and Class B ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net Income Minus Net Earnings</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,133,455</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,168,356</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Income allocable to ordinary shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> net income</div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,109,113</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,138,664</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding, basic and diluted</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,986,818</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,268,210</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.28</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.31</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr></table> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with the requirements of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 340-10-S99-1 and</div></div></div> SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $17,212,069 have been charged to shareholders’ equity (consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs). Of the total transaction cost $475,053 was reclassed to expense as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a non-operating expense</div> in the statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares. </div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Warrant Liabilities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Accounting Standards <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Codification 815-40, Derivatives</div> and Hedging; Contracts in Entity’s Own Equity (“ASC 815<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company accounts for its 12,333,333 warrants issued in connection with its IPO (6,600,000) and private placement (5,733,333) as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to re-measurement at</div> each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the IPO and private placement has been estimated using Monte-Carlo simulations at each measurement date. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basis of Presentation </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 10-Q and</div> Article 8 of <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Regulation S-X of</div> the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its IPO as filed with the SEC on March 10, 2021, as well as the Company’s Current Reports on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Form 8-K. The</div> interim results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Emerging Growth Company Status </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to non-emerging growth</div> companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Use of Estimates </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Cash and Cash Equivalents </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">As of<br/> June 30, 2021 and December 31, 2020, the Company had $529,587 and $25,000 in cash, respectively. The Company had no cash equivalents as of<br/> June 30, 2021 and December 31, 2020.</div> </div></div> 529587 25000 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Marketable Securities Held in Trust Account </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">At June 30, 2021, the Trust Account had $330,029,692 held in primarily U.S. Treasury bills. During period January 1, 2021 to June 30, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations. </div></div> 330029692 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Concentration of Credit Risk </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2021, the Company has not experienced losses on this account. </div></div> 250000 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Ordinary shares Subject to Possible Redemption </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021, 30,263,182 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet. </div></div> 30263182 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net Income (Loss) per Common Share </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the two-class method</div> of income (loss) per share. Net income per ordinary shares, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account totaling $5,350 for the three months ended June 30, 2021 by the weighted average number of Class A ordinary shares outstanding since original issuance. Net loss per ordinary shares, basic and diluted for Class B ordinary shares is calculated by dividing the net income, adjusted for income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Class B ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The basic and diluted loss per ordinary share is calculated as follows: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Class A ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Earnings allocable to Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company portion available to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30,263,182</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,943,752</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Class A and Class B ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net Income Minus Net Earnings</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,133,455</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,168,356</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Income allocable to ordinary shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> net income</div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,109,113</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,138,664</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding, basic and diluted</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,986,818</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,268,210</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.28</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.31</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr></table> 5350 The basic and diluted loss per ordinary share is calculated as follows: <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="font-size: 0px;"> <td style="width: 72%;"/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 5%; vertical-align: bottom;"/> <td/> <td/> <td/></tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Three Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom-color: rgb(0, 0, 0); border-bottom-width: 1pt; border-bottom-style: solid;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Six Months<br/> Ended<br/> June 30, 2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redeemable Class A ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Earnings allocable to Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Interest earned on marketable securities held in Trust Account</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Company portion available to pay taxes</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income allocable to shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Denominator: Weighted Average Redeemable Class A ordinary shares</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted weighted average shares outstanding</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">30,263,182</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,943,752</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">—</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> Class A and Class B ordinary shares</div></div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Numerator: Net Income Minus Net Earnings</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"> </td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Net income</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,133,455</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,168,356</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 3em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Less: Income allocable to ordinary shares subject to possible redemption</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">24,342</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">29,692</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 5em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Non-Redeemable</div> net income</div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,109,113</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">3,138,664</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Weighted average shares outstanding, basic and diluted</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,986,818</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">10,268,210</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; font-size: 10pt;"><div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Basic and diluted net income per ordinary share</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.28</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">0.31</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td></tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td> <td style="vertical-align: bottom;"><div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div></td></tr></table> 24342 29692 24342 29692 30263182 29943752 0 0 3133455 3168356 24342 29692 3109113 3138664 10986818 10268210 0.28 0.31 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Offering Costs </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company complies with the requirements of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">ASC 340-10-S99-1 and</div></div></div> SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $17,212,069 have been charged to shareholders’ equity (consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs). Of the total transaction cost $475,053 was reclassed to expense as <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a non-operating expense</div> in the statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares. </div> 17212069 6090000 10657500 464569 475053 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair Value of Financial Instruments </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Derivative Warrant Liabilities </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Accounting Standards <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Codification 815-40, Derivatives</div> and Hedging; Contracts in Entity’s Own Equity (“ASC 815<div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.</div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company accounts for its 12,333,333 warrants issued in connection with its IPO (6,600,000) and private placement (5,733,333) as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">to re-measurement at</div> each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the IPO and private placement has been estimated using Monte-Carlo simulations at each measurement date. </div> 12333333 6600000 5733333 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Income Taxes </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. </div></div> 0 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 3 — Initial Public Offering </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Pursuant to the IPO, the Company sold 33,000,000 Units, (at a price of $10.00 per Unit. Each Unit consists of one share of Class A ordinary shares, par value $0.0001 per <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">share one-fifth of</div> one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share. </div> 33000000 10.00 Each Unit consists of one share of Class A ordinary shares, par value $0.0001 per share one-fifth of one redeemable warrant (“Public Warrant”). 0.0001 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 4 — Private Placement Warrants </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,733,333 Private Placement Warrants at a price of $1.50 per warrant ($8,600,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants will be identical to the warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to certain registration rights. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Sponsor has agreed to (i) waive its redemption rights with respect to its Founder Shares and public shares in connection with the completion of the initial Business Combination, (ii) waive its redemption rights with respect to its Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">or pre-initial Business</div> Combination activity, (iii) waive its rights to liquidating distributions from the Trust Account with respect to its Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any Founder Shares held by the Sponsor and any public shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business Combination. </div> 5733333 1.50 8600000 1 11.50 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 5 — Related Party Transactions </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Founder Shares </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On December 31, 2020, the Company issued 7,187,500 Class B ordinary shares to the Sponsor for an aggregate purchase price of $25,000. On February 24, 2021, the Company effected a share capitalization of 1,437,500 shares, resulting in 8,625,000 shares of Class B ordinary shares being issued and outstanding. Up to 1,125,000 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On March 12, 2021, the underwriter partially exercised the over-allotment option and therefore 375,000 Founder Shares were forfeited, and 750,000 Founder Shares are no longer subject to forfeiture, resulting in 8,250,000 Founder Shares outstanding at June 30, 2021. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(the “lock-up”).</div> </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Notwithstanding the foregoing, if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">share sub-divisions, share</div> capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">any 30-trading day</div> period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released <div style="letter-spacing: 0px; top: 0px;;display:inline;">from <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">the lock-up.</div> </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Promissory Note — Related Party </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;">On December 17, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">are non-interest bearing,</div> unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the offering proceeds that has been allocated to the payment of offering expenses. As of June 30, 2021, there was no outstanding balance under the promissory note. </div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Administrative Support Agreement </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;">Commencing on the date of the IPO, the Company has agreed to pay the Sponsor a total of $30,000 per month for office space and administrative support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;;display:inline;">For the three and six month periods ended June 30, 2021, the Company has incurred $111,290 </div></div><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;; font-size: 13.3333px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: left; text-indent: 0px; text-transform: none; white-space: normal; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; background-color: rgb(255, 255, 255); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; float: none; display: inline !important; top: 0px;;display:inline;">in expense pursuant to this agreement. All outstanding fees owed are paid and thus nothing is accrued as of June 30, 2021.</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px; text-indent: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Working Capital Loans </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In addition, <div style="letter-spacing: 0px; top: 0px;;display:inline;">in<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of </div><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">June 30</div>,</div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> 2021, the Company had not outstanding borrowings under the Working Capital Loans. </div></div> 7187500 25000 1437500 8625000 1125000 375000 750000 8250000 P1Y 12.00 P20D P30D P150D 300000 0 30000 111290 111290 1500000 1.50 0 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 6 — Commitments &amp; Contingencies </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Registration Rights </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants which will be issued in a private placement simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Underwriters Agreement </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">On March 12, 2021, the Company paid a fixed underwriting discount of $6,090,000. Additionally, a deferred underwriting discount of $10,657,500 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement. </div></div> -6090000 10657500 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 7 — Shareholders’ Equity </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Preference shares</div></div></div></div> — The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. At June 30, 2021, there were no shares of preference shares issued or outstanding. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A ordinary shares</div></div></div></div> — The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 2,736,818 and 0 shares issued and outstanding (excluding 30,263,182 and 0 shares subject to possible redemption), respectively </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Class</div></div></div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> B ordinary shares</div></div></div></div> — The Company is authorized to issue a total of 50,000,000 Class B ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 8,250,000 and 8,625,000 shares of Class B ordinary shares issued or outstanding, respectively. </div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders. </div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a one-for-one basis,</div></div> subject to adjustment for <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">share sub-divisions, share</div> capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity- linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;"><div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">than one-for-one basis.</div></div></div> 5000000 0.0001 0 0 500000000 500000000 0.0001 0.0001 2736818 2736818 0 0 30263182 0 50000000 50000000 0.0001 0.0001 8250000 8250000 8625000 8625000 0.20 one-for-one basis <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 8 — Warrants </div></div></div> <div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Sponsor or its affiliate, without taking into account any Founder Shares held by the Sponsor or such affiliate, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, the $18.00 per share redemption trigger prices described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price. </div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants will become exercisable 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, or earlier upon redemption or liquidation. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement o, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. </div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00 </div></div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Once the warrants become exercisable, the Company may redeem the outstanding warrants: </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">upon not less than 30 days’ prior written notice of redemption to each warrant holder <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">(the “30-day redemption</div> period”); and </div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the reported sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a 30-trading day</div> period ending three business days before the Company sends to the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">In no event will the Company be required to net cash settle any warrants. </div></div><div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Redemption of Warrants when the price per Class</div></div><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> A Ordinary Share equals or exceeds $10.00.</div></div> The Company may also redeem the outstanding Public Warrants once they become exercisable: </div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.10 per warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">upon a minimum of 30 days’ prior written notice of redemption;<div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;"> provided</div></div> that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; and </div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 10%;"> </td> <td style="width: 2%; vertical-align: top;;text-align:left;">•</td> <td style="width: 1%; vertical-align: top;"> </td> <td style="vertical-align: top;;text-align:left;"><div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a 30-trading day</div> period ending three trading days before the Company sends the notice of redemption to the warrant holders. </div></td></tr></table><div style="clear: both; max-height: 0px;"/><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company is unable to complete the initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div> 11.50 9.20 0.60 P10D 9.20 1.15 18.00 1.80 10.00 P30D P5Y P15D P60D 18.00 0.01 P30D 18.00 P20D P30D 10.00 0.10 P30D 10.00 P20D P30D <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 9 — Fair Value Measurements </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. Contracts in Entity’s Own Equity (“ASC 815”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include: </div></div></div> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets; </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:100%;"> <tr style="page-break-inside: avoid;"> <td style="width: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="width: 5%; vertical-align: top;;text-align:left;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">•</div></td> <td style="vertical-align: top; font-size: 10pt;;text-align:left;"> <div style="text-align: left; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. </div></div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:</div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="5" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Prices In</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Active</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities – Public Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities – Private Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,368,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> —  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The Company utilizes a Black Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S. <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">Treasury zero-coupon yield</div> curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate, </div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">which the Company anticipates to remain at zero. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The aforementioned warrant liabilities are not subject to qualified hedge accounting. </div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">There were </div></div>no <div style="font-size: 10pt; letter-spacing: 0px; text-indent: 4%; top: 0px;;display:inline;">transfers between Levels 1, 2 or 3 during the quarter ended<div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">June 30, 2021. </div></div></div> <div style="font-size: 8pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 8pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements: </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> </div> </div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Initial</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measurement)</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Initial</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measurement)</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 92%; font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">               </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">               </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.70</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.70</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term (in years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">24.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">24.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption trigger price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">18.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <br/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 96%;"> </td> <td style="width: 1%; vertical-align: bottom;"> </td> <td> </td> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                  </div></div></td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 96%; font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">                  </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.77</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term (in years)</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; padding: 0px; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">19.2</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.94</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption trigger price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of warrant liabilities: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public </div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:62.0%; padding:0in 0in 0in 0in"/> <td style="width:4.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="width:3.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="width:3.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> </tr> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of November 24, 2020</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial measurement on March 12, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,108,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,313,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,421,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; width: 61%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(264,001</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(286,666</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(550,667</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; width: 61%; background-color: rgb(255, 255, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,844,000</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,026,667</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">16,870,667</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; width: 61%; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(1,782,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(1,720,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(3,502,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 61%; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 61%; background-color: rgb(255, 255, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">13,368,667</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 61%; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 8pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:92%;"> <tr style="font-size: 0px;"> <td style="width: 56%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="5" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Quoted</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Significant</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Prices In</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Other</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Active</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Observable</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Unobservable</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Markets</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Inputs</div></div></div></td> <td style="vertical-align: bottom;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 1)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 2)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Level 3)</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Description</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities – Public Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Warrant liabilities – Private Warrants</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">13,368,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> 7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"> —  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom;"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td> </td> </tr> </table> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt;"/> 7062000 7062000 0 0 6306667 0 0 6306667 13368667 7062000 0 6306667 0 <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table provides quantitative information regarding Level 3 fair value measurements: </div></div></div> <div style="text-indent: 4%; font-family: Times New Roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"/> <div style="text-align: center;"> <div style="width: 8.5in; text-align: left; margin-right: auto; margin-left: auto;"> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> </div> </div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;">  </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Initial</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measurement)</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">March 12,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">(Initial</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Measurement)</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 92%; font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">               </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">               </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.70</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.70</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term (in years)</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">24.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">24.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.98</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption trigger price</div></div> </td> <td style="vertical-align: bottom;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">18.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <br/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:76%;"> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 96%;"> </td> <td style="width: 1%; vertical-align: bottom;"> </td> <td> </td> <td style="white-space: nowrap;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">                  </div></div></td> <td> </td> </tr> <tr style="page-break-inside:avoid ; font-family:Def.-Times; font-size:8pt"> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">At</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">June 30,</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">2021</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div><br/> <div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrants</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"> </td> </tr> <tr style="color: white; line-height: 0pt; visibility: hidden;"> <td style="width: 96%; font-family: &quot;Times New Roman&quot;;"> </td> <td style="width: 1%; vertical-align: bottom; font-family: &quot;Times New Roman&quot;;"> </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> <td style="white-space: nowrap;">                  </td> <td style="font-family: &quot;Times New Roman&quot;;"> </td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Share price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">9.77</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Strike price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">11.50</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Term (in years)</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">5.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Volatility</div></div> </td> <td style="vertical-align: bottom; padding: 0px; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">19.2</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Risk-free rate</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.94</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Dividend yield</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.0</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">% </div></td> </tr> <tr style="font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 96%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Redemption trigger price</div></div> </td> <td style="vertical-align: bottom; width: 1%;"> </td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;">0.00</div></td> <td style="vertical-align: bottom; white-space: nowrap;"><div style="font-family: &quot;Times New Roman&quot;; letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 9.70 9.70 11.50 11.50 P5Y P5Y 0.240 0.240 0.0098 0.0098 0.000 0.000 18.00 0.00 9.77 11.50 P5Y 0.192 0.0094 0.000 0.00 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt; margin-left: 4%; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The following table presents the changes in the fair value of warrant liabilities: </div></div></div> <div style="font-size: 12pt; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-size: 12pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></div> <table cellpadding="0" cellspacing="0" style="margin: 0px auto; border: 0px currentcolor; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-collapse: collapse; border-spacing: 0px; text-indent: 0px;;width:84%;"> <tr style="font-size: 0px;"> <td style="width: 62%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" rowspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Public </div></div></div></td> <td rowspan="2" style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Private </div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; padding-bottom: 1pt;;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Warrant</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-family: Times New Roman; font-size: 8pt; page-break-inside: avoid;"> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Placement</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td colspan="2" style="vertical-align: bottom; border-bottom: 1pt solid rgb(0, 0, 0);;text-align:center;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Liabilities</div></div></div></td> <td style="vertical-align: bottom; padding-bottom: 1pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> </tr> <tr style="font-size: 0px;"> <td style="width:62.0%; padding:0in 0in 0in 0in"/> <td style="width:4.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="width:3.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="width:3.0%; padding:0in 0in 0in 0in;vertical-align:bottom;"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> <td style="padding:0in 0in 0in 0in"/> </tr> <tr style="font-size: 0px;"> <td style="width: 61%;"/> <td style="width: 4%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> <td style="width: 3%; vertical-align: bottom;"/> <td/> <td/> <td/> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid; background-color: rgb(204, 238, 255);"> <td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of November 24, 2020</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;">$</td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">—  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 61%;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Initial measurement on March 12, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">9,108,000</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">8,313,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; width: 3%;">  </td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> <td style="vertical-align: bottom; white-space: nowrap;;text-align:right;">17,421,333</td> <td style="vertical-align: bottom; white-space: nowrap;"> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; width: 61%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(264,001</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(286,666</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">) </div></td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); border-bottom: 0.75pt solid black;;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">(550,667</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255); padding-bottom: 0.75pt;"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">)</div></div> </td> </tr> <tr> <td style="vertical-align: top; font-size: 10pt; width: 61%; background-color: rgb(255, 255, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of March 31, 2021</div></div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">  </div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"><div style="letter-spacing: 0px; top: 0px;;display:inline;">$</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,844,000</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">8,026,667</div></td> <td style="white-space:nowrap;vertical-align:bottom"> </td> <td style="vertical-align:bottom">  </td> <td style="white-space:nowrap;vertical-align:bottom">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">16,870,667</div></td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> <div style="margin-bottom: 0px; margin-top: 0px; line-height: normal;"> </div> </td> </tr> <tr style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; break-inside: avoid;"> <td style="vertical-align: top; width: 61%; background-color: rgb(204, 238, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Change in valuation inputs or other assumptions</div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(1,782,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(1,720,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(204, 238, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);"> </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);;text-align:right;">(3,502,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(204, 238, 255);">) </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 61%; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1px solid rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-family: Times New Roman; font-size: 10pt; page-break-inside: avoid;"> <td style="vertical-align: top; width: 61%; background-color: rgb(255, 255, 255);"> <div style="text-indent: -1em; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1em; line-height: normal;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Fair value as of June 30, 2021</div></div> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">7,062,000</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">6,306,667</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);">$</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);;text-align:right;">13,368,667</td> <td style="vertical-align: bottom; white-space: nowrap; background-color: rgb(255, 255, 255);"> </td> </tr> <tr style="font-size: 1px;"> <td style="vertical-align: bottom; font-family: &quot;Times New Roman&quot;; width: 61%; background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 4%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> <td style="vertical-align: bottom; width: 3%; background-color: rgb(255, 255, 255);">  </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <div style="margin-top: 0pt; margin-bottom: 0pt; border-top: 3px double rgb(0, 0, 0); line-height: normal;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="background-color: rgb(255, 255, 255);"> </td> </tr> </table> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> 9108000 8313333 17421333 -264001 -286666 -550667 8844000 8026667 16870667 -1782000 -1720000 -3502000 7062000 6306667 13368667 <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Note 10 — Subsequent Events </div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt; text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. </div></div></div> XML 10 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover Page - shares
 6 Months Ended
Jun. 30, 2021
Aug. 23, 2021
Document Information [Line Items]    
Document Type 10-Q  
Document Period End Date Jun. 30, 2021  
Amendment Flag false  
Document Fiscal Period Focus Q2  
Document Fiscal Year Focus 2021  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Entity Registrant Name COLONNADE ACQUISITION CORP. II  
Entity Interactive Data Current Yes  
Current Fiscal Year End Date --12-31  
Entity Central Index Key 0001837739  
Document Quarterly Report true  
Document Transition Report false  
Entity Shell Company true  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity File Number 001-40184  
Entity Incorporation, State or Country Code E9  
Entity Address, Address Line One 1400 Centrepark Blvd  
Entity Address, Address Line Two Ste 810  
Entity Address, City or Town West Palm Beach  
Entity Address, Postal Zip Code 33401  
City Area Code 561  
Local Phone Number 712-7860  
Entity Address, State or Province FL  
Capital Units [Member]    
Document Information [Line Items]    
Title of 12(b) Security Units, each consisting of one Class A ordinary share, $0.0001 par value, and one-fifth of one redeemable warrant  
Trading Symbol CLAA.U  
Security Exchange Name NYSE  
Warrant [Member]    
Document Information [Line Items]    
Title of 12(b) Security Redeemable warrants, each warrant exercisable for one Class A ordinary share, each at an exercise price of $11.50 per share  
Trading Symbol CLAA WS  
Security Exchange Name NYSE  
Common Class A [Member]    
Document Information [Line Items]    
Title of 12(b) Security Class A ordinary shares, par value $0.0001 par value  
Trading Symbol CLAA  
Security Exchange Name NYSE  
Entity Common Stock, Shares Outstanding   33,000,000
Common Class B [Member]    
Document Information [Line Items]    
Entity Common Stock, Shares Outstanding   8,250,000
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets - USD ($)
Jun. 30, 2021
Dec. 31, 2020
Current assets:    
Cash $ 529,587 $ 25,000
Prepaid expenses 1,164,254  
Deferred offering costs associated with IPO   61,814
Total current assets 1,693,841 86,814
Cash and investment held in trust account 330,029,692  
Total assets 331,723,533 86,814
Current liabilities:    
Accounts payable and accrued expenses 65,546 35,000
Promissory Note – related party   30,000
Total current liabilities 65,546 65,000
Warrant Liabilities 13,368,666  
Deferred underwriters' discount 10,657,500  
Total liabilities 24,091,712 65,000
Commitments
Class A ordinary shares subject to possible redemption 30,263,182 shares at redemption value 302,631,817  
Shareholders' equity:    
Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding
Additional paid-in capital 1,833,735 24,137
Accumulated earnings (deficit) 3,165,170 (3,186)
Total shareholders' equity 5,000,004 21,814
Total liabilities and shareholders' equity 331,723,533 86,814
Common Class A [Member]    
Shareholders' equity:    
Common stock value 274 0
Common Class B [Member]    
Shareholders' equity:    
Common stock value $ 825 $ 863
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2021
Dec. 31, 2020
Temporary equity shares outstanding 30,263,182 0
Preferred stock par value per share $ 0.0001 $ 0.0001
Preferred stock shares authorized 5,000,000 5,000,000
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Common Class A [Member]    
Temporary equity shares outstanding 30,263,182 0
Common stock par value per share $ 0.0001 $ 0.0001
Common stock shares authorized 500,000,000 500,000,000
Common stock shares issued 2,736,818 0
Common stock shares outstanding 2,736,818 0
Common Class B [Member]    
Common stock par value per share $ 0.0001 $ 0.0001
Common stock shares authorized 50,000,000 50,000,000
Common stock shares issued 8,250,000 8,625,000
Common stock shares outstanding 8,250,000 8,625,000
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Jun. 30, 2021
Formation and operating costs $ 392,887 $ 438,950
Loss from operations (392,887) (438,950)
Other Income (Loss)    
Interest income 24,342 29,692
Change in fair value of warrant liabilities 3,502,000 4,052,667
Offering expenses related to warrant issuance 0 (475,053)
Total other income 3,526,342 3,607,306
Net income $ 3,133,455 $ 3,168,356
Class A ordinary shares subject to possible redemption [Member]    
Other Income (Loss)    
Weighted average shares outstanding 30,263,182 29,943,752
Basic and diluted net income/loss per share $ 0.00 $ 0.00
Non-redeemable ordinary shares [Member]    
Other Income (Loss)    
Weighted average shares outstanding 10,986,818 10,268,210
Basic and diluted net income/loss per share $ 0.28 $ 0.31
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statements of Changes in Shareholders' Equity - USD ($)
Total
Common Class B [Member]
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Additional Paid-In Capital [Member]
Accumulated Earnings (Deficit) [Member]
Beginning balance at Dec. 31, 2020 $ 21,814     $ 863 $ 24,137 $ (3,186)
Beginning balance, Shares at Dec. 31, 2020       8,625,000    
Sale of Units in Initial Public Offering, net of underwriter fee 330,000,000   $ 3,300   329,996,700  
Sale of Units in Initial Public Offering, net of underwriter fee, Shares     33,000,000      
Sale of private placement 8,600,000       8,600,000  
Initial fair value of warrants accounted for as liabilities (17,421,333)       (17,421,333)  
Underwriter discount (6,090,000)       (6,090,000)  
Deferred underwriter discount (10,657,500)       (10,657,500)  
Other offering cost charged to shareholders' equity (464,569)       (464,569)  
Sponsor forfeiture of shares       $ (38) 38  
Sponsor forfeiture of shares, Shares       (375,000)    
Reclassification of offering cost related to warrant issuance 475,053       475,053  
Class A ordinary shares subject to possible redemption (299,498,363)   $ (2,995)   (299,495,368)  
Class A ordinary shares subject to possible redemption, Shares     29,949,836      
Net income 34,901         34,901
Ending balance at Mar. 31, 2021 5,000,003   $ 305 $ 825 4,967,158 31,715
Ending balance, Shares at Mar. 31, 2021     3,050,164 8,250,000    
Beginning balance at Dec. 31, 2020 21,814     $ 863 24,137 (3,186)
Beginning balance, Shares at Dec. 31, 2020       8,625,000    
Sale of private placement   $ 25,000        
Underwriter discount (6,090,000)          
Reclassification of offering cost related to warrant issuance 475,053          
Net income 3,168,356          
Ending balance at Jun. 30, 2021 5,000,004   $ 274 $ 825 1,833,735 3,165,170
Ending balance, Shares at Jun. 30, 2021     2,736,818 8,250,000    
Beginning balance at Mar. 31, 2021 5,000,003   $ 305 $ 825 4,967,158 31,715
Beginning balance, Shares at Mar. 31, 2021     3,050,164 8,250,000    
Reclassification of offering cost related to warrant issuance 0          
Class A ordinary shares subject to possible redemption (3,133,454)   $ (31)   (3,133,423)  
Class A ordinary shares subject to possible redemption, Shares     (313,346)      
Net income 3,133,455         3,133,455
Ending balance at Jun. 30, 2021 $ 5,000,004   $ 274 $ 825 $ 1,833,735 $ 3,165,170
Ending balance, Shares at Jun. 30, 2021     2,736,818 8,250,000    
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Statement of Cash Flows
 6 Months Ended
Jun. 30, 2021
USD ($)
Cash Flows from Operating Activities:  
Net income $ 3,168,356
Adjustments to reconcile net income to net cash used in operating activities:  
Interest earned on trust account (29,692)
Change in fair value of warrant liabilities (4,052,667)
Offering costs allocated to warrants 475,053
Changes in current assets and current liabilities:  
Prepaid assets (1,164,254)
Accounts payable 65,546
Net cash used in operating activities (1,537,658)
Cash Flows from Investing Activities:  
Investment of cash into trust account (330,000,000)
Net cash used in investing activities (330,000,000)
Cash Flows from Financing Activities:  
Proceeds from Initial Public Offering, net of underwriters' discount 323,910,000
Proceeds from issuance of Private Placement Warrants 8,600,000
Proceeds from issuance of promissory note to related party 115,824
Repayment of promissory note to related party (145,824)
Payments of offering costs (437,755)
Net cash provided by financing activities 332,042,245
Net Change in Cash 504,587
Cash - Beginning 25,000
Cash - Ending 529,587
Supplemental Disclosure of Non-cash Financing Activities:  
Initial value of warrant liabilities 17,421,333
Deferred underwriters' discount payable charged to additional paid-in capital 10,657,500
Class A Common Stock [Member]  
Supplemental Disclosure of Non-cash Financing Activities:  
Initial value of Class A ordinary shares subject to possible redemption 298,977,981
Change in value of Class A ordinary shares subject to possible redemption $ 3,653,836
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.21.2
Organization and Business Operations
 6 Months Ended
Jun. 30, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Business Operations
Note 1 — Organization and Business Operations
Organization and General
Colonnade Acquisition Corp. II (the “Company”) was incorporated in Cayman Islands on November 24, 2020. The Company was formed for the purpose of entering into a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (a “Business Combination”). The Company is not limited to a particular industry or geographic region for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies. The Company has selected December 31 as its fiscal year end.
As of June 30, 2021, the Company had not yet commenced any operations. All activity through June 30, 2021, relates to the Company’s formation and the Initial Public Offering (“IPO”) described below. The Company will not generate any operating revenues until after the completion of its initial business combination, at the earliest. The Company will
generate non-operating income
in the form of interest income on cash and cash equivalents from the proceeds derived from the IPO.
Financing
The registration statement for the Company’s IPO was declared effective on March 9, 2021 (the “Effective Date”). On March 12, 2021, the Company consummated the IPO of 33,000,000 units (the “Units” and, with respect to the Class A ordinary shares included in the Units being offered, the “public share”), at $10.00 per Unit, generating gross proceeds of $330,000,000, which is discussed in Note 3.
Simultaneously with the closing of the IPO, the Company consummated the sale of 5,733,333 warrants (the “Private Placement Warrant”), at a price of $1.50 per Private Placement Warrant, which is discussed in Note 4.
Transaction costs amounted to $17,212,069 consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs. Of the total transaction cost $475,053 was expensed
as non-operating expenses
in that statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares.
Trust Account
Following the closing of the IPO on March 15, 2021, an amount of $330,000,000 from the net proceeds of the sale of the Units in the IPO and the sale of the Private Placement Warrants was placed in a trust account (“Trust Account”) which is invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 185 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of
Rule 2a-7 of
the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the trust account that may be released to the Company to pay its tax obligations, the proceeds from the IPO and the sale of the Private Placement Warrants will not be released from the trust account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly submitted in connection with a shareholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial business combination within 24 months from the closing of the IPO, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public shareholders.
 
Initial Business Combination
The Company’s management has broad discretion with respect to the specific application of the net proceeds of the IPO, although substantially all of the net proceeds are intended to be generally applied toward consummating a business combination.
The Company’s business combination must be with one or more target businesses that together have a fair market value equal to at least 80% of the balance in the Trust Account (net of taxes payable) at the time of the signing an agreement to enter into a business combination. However, the Company will only complete a business combination if the post-business combination company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target sufficient for it not to be required to register as an investment company under the Investment Company Act. There is no assurance that the Company will be able to successfully effect a business combination.
The Company will provide its public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a shareholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek shareholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The shareholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially $10.00 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations).
The shares of ordinary shares subject to redemption is recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a business combination if the Company has net tangible assets of at least $5,000,001 either immediately prior to or upon consummation of a business combination and, if the Company seeks shareholder approval, a majority of the issued and outstanding shares voted are voted in favor of the business combination.
The Company will have until March 12, 2023 (with the ability to extend with shareholder approval) to consummate a business combination (the “Combination Period”). However, if the Company is unable to complete a business combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the Trust Account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate.
The Company’s sponsor, Colonnade Sponsor II LLC (the “Sponsor”), officers and directors have agreed to (i) waive their redemption rights with respect to the 7,187,500 Class B ordinary shares issued to the Sponsor for an aggregate purchase price of $25,000 on December 31, 2020 (the “Founder Shares”) and public shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their Founder Shares if the Company fails to complete the initial business combination within the Combination Period.
The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such
 
liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of the IPO against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations.
Going Concern
As of June 30, 2021, the Company had cash outside the Trust Account of $529,587 available for working capital needs. All remaining cash held in the Trust Account are generally unavailable for the Company’s use, prior to an initial business combination, and is restricted for use either in a Business Combination or to redeem ordinary shares. As of June 30, 2021, none of the amount in the Trust Account was available to be withdrawn as described above.
Through June 30, 2021, the Company’s liquidity needs were satisfied through rec
e
ipt of $25,000 from the sale of the Founder Shares and the remaining net proceeds from the IPO and the sale of Private Placement Warrants.
In order to fund working capital deficiencies or finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required. If the Company completes a Business Combination, it would repay such loaned amounts. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay such loaned amounts, but no proceeds from the Trust Account would be used for such repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a price of $1.50 per warrant unit at the option of the lender. The warrants would be identical to the Private Placement Warrants.
Until the consummation of a Business Combination, the Company will be using the funds not held in the Trust Account for identifying and evaluating prospective acquisition candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to acquire, and structuring, negotiating and consummating the Business Combination. The Company may need to raise additional capital through loans or additional investments from its Sponsor, shareholders, officers, directors, or third parties. The Company’s Sponsor, officers and directors may, but are not obligated to, loan the Company funds from time to time or at any time, in whatever amount they deem reasonable in their sole discretion, to meet the Company’s working capital needs. Accordingly, the Company may not be able to obtain additional financing. If the Company is unable to raise additional capital, it may be required to take additional measures to conserve liquidity, which could include, but not necessarily be limited to, curtailing operations, suspending the pursuit of a potential transaction, and reducing overhead expenses.
The Company cannot provide any assurance that new financing will be available to it on commercially acceptable terms, if at all. These conditions raise substantial doubt about the Company’s ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate. These financial statements do not include any adjustments relating to the recovery of the recorded assets or the classification of the liabilities that might be necessary should the Company be unable to continue as a going concern.
Risks and Uncertainties
On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus
(the “COVID-19 outbreak”). In
March 2020, the WHO
classified the COVID-19 outbreak as
a pandemic, based on the rapid increase in exposure globally. The full impact
of the COVID-19 outbreak continues
to evolve. The impact
of the COVID-19 outbreak on
the Company’s financial position will depend on future developments, including the duration and spread of the outbreak and related advisories and restrictions. These developments and the impact
of the COVID-19 outbreak on
the financial markets and the overall economy are highly uncertain and cannot be predicted. If the financial markets and/or the overall economy are impacted for an extended period, the Company’s financial position may be materially adversely affected. Additionally, the Company’s ability to complete an initial business combination may be materially adversely affected due to significant governmental measures being implemented to
contain the COVID-19 outbreak or
treat its impact, including travel restrictions, the shutdown of businesses and quarantines, among others, which may limit the Company’s ability to have meetings with potential investors or affect the ability of a potential target company’s personnel, vendors and service providers to negotiate and consummate an initial business combination in a timely manner. The Company’s ability to consummate an initial business combination may also be dependent on the ability to raise additional equity and debt financing, which may be impacted
by the COVID-19 outbreak and
the resulting market downturn.
 
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2— Significant Accounting Policies
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X of
the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its IPO as filed with the SEC on March 10, 2021, as well as the Company’s Current Reports on
Form 8-K. The
interim results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
 
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
 
As of
June 30, 2021 and December 31, 2020, the Company had $529,587 and $25,000 in cash, respectively. The Company had no cash equivalents as of
June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
At June 30, 2021, the Trust Account had $330,029,692 held in primarily U.S. Treasury bills. During period January 1, 2021 to June 30, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations.
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2021, the Company has not experienced losses on this account.
Ordinary shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021, 30,263,182 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to
the two-class method
of income (loss) per share. Net income per ordinary shares, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account totaling $5,350 for the three months ended June 30, 2021 by the weighted average number of Class A ordinary shares outstanding since original issuance. Net loss per ordinary shares, basic and diluted for Class B ordinary shares is calculated by dividing the net income, adjusted for income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Class B ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.
The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
The basic and diluted loss per ordinary share is calculated as follows:
 
 
  
Three Months
Ended
June 30, 2021
 
  
Six Months
Ended
June 30, 2021
 
Redeemable Class A ordinary shares
  
      
  
      
Numerator: Earnings allocable to Redeemable Class A ordinary shares
  
      
  
      
Interest earned on marketable securities held in Trust Account
  
$
24,342
 
  
$
29,692
 
Less: Company portion available to pay taxes
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Net income allocable to shares subject to possible redemption
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Denominator: Weighted Average Redeemable Class A ordinary shares
  
      
  
      
Basic and diluted weighted average shares outstanding
  
 
30,263,182
 
  
 
29,943,752
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
Class A and Class B ordinary shares
  
      
  
      
Numerator: Net Income Minus Net Earnings
  
      
  
      
Net income
  
$
3,133,455
 
  
$
3,168,356
 
Less: Income allocable to ordinary shares subject to possible redemption
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
net income
  
$
3,109,113
 
  
$
3,138,664
 
 
  
 
 
 
  
 
 
 
Weighted average shares outstanding, basic and diluted
  
 
10,986,818
 
  
 
10,268,210
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
0.28
 
  
$
0.31
 
 
  
 
 
 
  
 
 
Offering Costs
The Company complies with the requirements of the
ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $17,212,069 have been charged to shareholders’ equity (consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs). Of the total transaction cost $475,053 was reclassed to expense as
a non-operating expense
in the statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares.
 
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Accounting Standards
Codification 815-40, Derivatives
and Hedging; Contracts in Entity’s Own Equity (“ASC 815
”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.
The Company accounts for its 12,333,333 warrants issued in connection with its IPO (6,600,000) and private placement (5,733,333) as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the IPO and private placement has been estimated using Monte-Carlo simulations at each measurement date.
Income Taxes
The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 18 R9.htm IDEA: XBRL DOCUMENT v3.21.2
Initial Public Offering
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Initial Public Offering
Note 3 — Initial Public Offering
Pursuant to the IPO, the Company sold 33,000,000 Units, (at a price of $10.00 per Unit. Each Unit consists of one share of Class A ordinary shares, par value $0.0001 per
share one-fifth of
one redeemable warrant (“Public Warrant”). Each whole Public Warrant entitles the holder to purchase one share of Class A ordinary shares at a price of $11.50 per share.
XML 19 R10.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement Warrants
 6 Months Ended
Jun. 30, 2021
Warrants and Rights Note Disclosure [Abstract]  
Private Placement Warrants
Note 4 — Private Placement Warrants
Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of 5,733,333 Private Placement Warrants at a price of $1.50 per warrant ($8,600,000 in the aggregate), each Private Placement Warrant is exercisable to purchase one share of Class A ordinary shares at a price of $11.50 per share. A portion of the purchase price of the Private Placement Warrants was added to the proceeds from this offering to be held in the Trust Account.
The Private Placement Warrants will be identical to the warrants sold in the IPO except that the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Class A ordinary shares issuable upon exercise of these Private Placement Warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the Company’s initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to certain registration rights.
If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the warrants included in the units being sold in the IPO.
The Sponsor has agreed to (i) waive its redemption rights with respect to its Founder Shares and public shares in connection with the completion of the initial Business Combination, (ii) waive its redemption rights with respect to its Founder Shares and public shares in connection with a shareholder vote to approve an amendment to the Company’s amended and restated memorandum and articles of association (A) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the initial Business Combination or to redeem 100% of the Company’s public shares if the Company has not consummated an initial Business Combination within the Combination Period or (B) with respect to any other material provisions relating to shareholders’ rights
or pre-initial Business
Combination activity, (iii) waive its rights to liquidating distributions from the Trust Account with respect to its Founder Shares if the Company fails to complete the initial Business Combination within the Combination Period, and (iv) vote any Founder Shares held by the Sponsor and any public shares purchased during or after the IPO (including in open market and privately-negotiated transactions) in favor of the initial Business Combination.
XML 20 R11.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions
 6 Months Ended
Jun. 30, 2021
Related Party Transactions [Abstract]  
Related Party Transactions
Note 5 — Related Party Transactions
Founder Shares
On December 31, 2020, the Company issued 7,187,500 Class B ordinary shares to the Sponsor for an aggregate purchase price of $25,000. On February 24, 2021, the Company effected a share capitalization of 1,437,500 shares, resulting in 8,625,000 shares of Class B ordinary shares being issued and outstanding. Up to 1,125,000 Founder Shares are subject to forfeiture by the Sponsor depending on the extent to which the underwriters’ over-allotment option is exercised. On March 12, 2021, the underwriter partially exercised the over-allotment option and therefore 375,000 Founder Shares were forfeited, and 750,000 Founder Shares are no longer subject to forfeiture, resulting in 8,250,000 Founder Shares outstanding at June 30, 2021.
The initial shareholders have agreed not to transfer, assign or sell any of their Founder Shares and any Class A ordinary shares issuable upon conversion thereof until the earlier to occur of: (i) one year after the completion of the initial Business Combination, or (ii) the date on which the Company completes a liquidation, merger, share exchange or other similar transaction after the initial Business Combination that results in all of the Company’s shareholders having the right to exchange their Class A ordinary shares for cash, securities or other property; except to certain permitted transferees and under certain circumstances
(the “lock-up”).
Notwithstanding the foregoing, if the closing price of Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for
share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like) for any 20 trading days within
any 30-trading day
period commencing at least 150 days after the initial Business Combination or (2) if the Company consummates a transaction after the initial Business Combination which results in the Company’s shareholders having the right to exchange their shares for cash, securities or other property, the Founder Shares will be released
from
the lock-up.
 
Promissory Note — Related Party
On December 17, 2020, the Sponsor agreed to loan the Company up to $300,000 to be used for a portion of the expenses of the IPO. These loans
are non-interest bearing,
unsecured and are due at the earlier of December 31, 2021 or the closing of the IPO. The loan will be repaid upon the closing of the IPO out of the offering proceeds that has been allocated to the payment of offering expenses. As of June 30, 2021, there was no outstanding balance under the promissory note.
Administrative Support Agreement
Commencing on the date of the IPO, the Company has agreed to pay the Sponsor a total of $30,000 per month for office space and administrative support services. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.
 
For the three and six month periods ended June 30, 2021, the Company has incurred $111,290 
in expense pursuant to this agreement. All outstanding fees owed are paid and thus nothing is accrued as of June 30, 2021.
Working Capital Loans
In addition,
in
 
order to finance transaction costs in connection with a Business Combination, the initial stockholders or an affiliate of the initial stockholders or certain of the Company’s directors and officers may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans, but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the lender’s discretion, up to $1,500,000 of such Working Capital Loans may be convertible into warrants of the post-Business Combination entity at a price of $1.50 per warrant. The warrants would be identical to the Private Placement Warrants. As of
June 30
,
2021, the Company had not outstanding borrowings under the Working Capital Loans.
XML 21 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments & Contingencies
 6 Months Ended
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]  
Commitments & Contingencies
Note 6 — Commitments & Contingencies
Registration Rights
The holders of the (i) Founder Shares, which were issued in a private placement prior to the closing of the IPO, (ii) Private Placement Warrants which will be issued in a private placement simultaneously with the closing of the IPO and the Class A ordinary shares underlying such Private Placement Warrants and (iii) Private Placement Warrants that may be issued upon conversion of Working Capital Loans have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands, excluding short form demands, that the Company registers such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to the Company’s completion of the initial Business Combination. The Company will bear the expenses incurred in connection with the filing of any such registration statements.
Underwriters Agreement
On March 12, 2021, the Company paid a fixed underwriting discount of $6,090,000. Additionally, a deferred underwriting discount of $10,657,500 will be payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes an initial Business Combination, subject to the terms of the underwriting agreement.
XML 22 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity
 6 Months Ended
Jun. 30, 2021
Stockholders' Equity Note [Abstract]  
Shareholders' Equity
Note 7 — Shareholders’ Equity
Preference shares
 — The Company is authorized to issue a total of 5,000,000 preference shares at par value of $0.0001 each. At June 30, 2021, there were no shares of preference shares issued or outstanding.
Class
 A ordinary shares
 — The Company is authorized to issue a total of 500,000,000 Class A ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 2,736,818 and 0 shares issued and outstanding (excluding 30,263,182 and 0 shares subject to possible redemption), respectively
Class
 B ordinary shares
 — The Company is authorized to issue a total of 50,000,000 Class B ordinary shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 8,250,000 and 8,625,000 shares of Class B ordinary shares issued or outstanding, respectively.
Holders of Class A ordinary shares and holders of Class B ordinary shares will vote together as a single class on all matters submitted to a vote of the Company’s shareholders except as required by law. Unless specified in the Company’s amended and restated memorandum and articles of association, or as required by applicable provisions of the Companies Act or applicable stock exchange rules, the affirmative vote of a majority of the Company’s ordinary shares that are voted is required to approve any such matter voted on by its shareholders.
The Class B ordinary shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of the initial Business Combination on
a one-for-one basis,
subject to adjustment for
share sub-divisions, share
capitalizations, reorganizations, recapitalizations and the like, and subject to further adjustment as provided herein. In the case that additional Class A ordinary shares or equity- linked securities are issued or deemed issued in connection with the initial Business Combination, the number of Class A ordinary shares issuable upon conversion of all Founder Shares will equal, in the aggregate, 20% of the total number of Class A ordinary shares outstanding after such conversion (after giving effect to any redemptions of Class A ordinary shares by public shareholders), including the total number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the Company in connection with or in relation to the consummation of the initial Business Combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial Business Combination and any Private Placement Warrants issued to the Sponsor, officers or directors upon conversion of Working Capital Loans; provided that such conversion of Founder Shares will never occur on a less
than one-for-one basis.
XML 23 R14.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants
 6 Months Ended
Jun. 30, 2021
Warrants and Rights Note Disclosure [Abstract]  
Warrants
Note 8 — Warrants
Each whole warrant entitles the holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional Class A ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.20 per Class A ordinary share (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and in the case of any such issuance to the Sponsor or its affiliate, without taking into account any Founder Shares held by the Sponsor or such affiliate, as applicable, prior to such issuance (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination on the date of the consummation of the initial Business Combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s Class A ordinary shares during the 10 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Value”) is below $9.20 per share, then the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Value, the $18.00 per share redemption trigger prices described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $18.00” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price, and the $10.00 per share redemption trigger price described below under “Redemption of Warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price.
 
The warrants will become exercisable 30 days after the completion of its initial Business Combination, and will expire five years after the completion of the Company’s initial Business Combination, or earlier upon redemption or liquidation.
The Company has agreed that as soon as practicable, but in no event later than fifteen (15) business days after the closing of the initial Business Combination, it will use its commercially reasonable efforts to file with the SEC a post-effective amendment to the registration statement o, under the Securities Act, of the Class A ordinary shares issuable upon exercise of the warrants. The Company will use its commercially reasonable efforts to cause the same to become effective and to maintain the effectiveness of such registration statement, and a current prospectus relating thereto, until the expiration or redemption of the warrants in accordance with the provisions of the warrant agreement. If a registration statement covering the Class A ordinary shares issuable upon exercise of the warrants is not effective by the sixtieth (60th) business day after the closing of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company will have failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption. Notwithstanding the above, if the Company’s Class A ordinary shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b)(1) of the Securities Act, the Company may, at its option, require holders of Public Warrants who exercise their warrants to do so on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event the Company so elect, it will not be required to file or maintain in effect a registration statement, and in the event the Company does not so elect, it will use its commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available.
Redemption of Warrants When the Price per Class A Ordinary Share Equals or Exceeds $18.00
Once the warrants become exercisable, the Company may redeem the outstanding warrants:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.01 per warrant;
 
  •  
upon not less than 30 days’ prior written notice of redemption to each warrant holder
(the “30-day redemption
period”); and
 
  •  
if, and only if, the reported sale price of the ordinary shares equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within
a 30-trading day
period ending three business days before the Company sends to the notice of redemption to the warrant holders.
In no event will the Company be required to net cash settle any warrants.
Redemption of Warrants when the price per Class
 A Ordinary Share equals or exceeds $10.00.
 The Company may also redeem the outstanding Public Warrants once they become exercisable:
 
  •  
in whole and not in part;
 
  •  
at a price of $0.10 per warrant;
 
  •  
upon a minimum of 30 days’ prior written notice of redemption;
 provided
 that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A ordinary shares; and
 
  •  
if, and only if, the last reported sale price of the Class A ordinary shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within
a 30-trading day
period ending three trading days before the Company sends the notice of redemption to the warrant holders.
If the Company is unable to complete the initial Business Combination within the combination period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.
XML 24 R15.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Note 9 — Fair Value Measurements
Fair value is defined as the price that would be received for sale of an asset or paid for transfer of a liability, in an orderly transaction between market participants at the measurement date. Contracts in Entity’s Own Equity (“ASC 815”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities. GAAP establishes a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 measurements) and the lowest priority to unobservable inputs (Level 3 measurements). These tiers include:
 
 
•
Level 1, defined as observable inputs such as quoted prices (unadjusted) for identical instruments in active markets;
 
 
•
Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and
 
 
•
Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
The following table presents information about the Company’s assets that are measured at fair value on a recurring basis at June 30, 2021 and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value:
 
 
  
 
 
  
Quoted
 
  
Significant
 
  
Significant
 
  
 
 
  
Prices In
 
  
Other
 
  
Other
 
  
 
 
  
Active
 
  
Observable
 
  
Unobservable
 
  
June 30,
 
  
Markets
 
  
Inputs
 
  
Inputs
 
  
2021
 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Description
                                    
Warrant liabilities – Public Warrants
      7,062,000        7,062,000        —          —    
Warrant liabilities – Private Warrants
      6,306,667        —          —          6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
     $ 13,368,667      $  7,062,000      $  —        $ 6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
The Company’s warrant liability for the Public Warrants is based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. The fair value of the Public Warrant liability is classified within Level 1 of the fair value hierarchy. The Company utilizes a Black Scholes model to value the Private Placement Warrants at each reporting period, with changes in fair value recognized in the statement of operations. The estimated fair value of the warrant liability is determined using Level 3 inputs. Inherent in a binomial options pricing model are assumptions related to expected share-price volatility, expected life, risk-free interest rate and dividend yield. The Company estimates the volatility of its ordinary shares based on historical volatility that matches the expected remaining life of the warrants. The risk-free interest rate is based on the U.S.
Treasury zero-coupon yield
curve on the grant date for a maturity similar to the expected remaining life of the warrants. The expected life of the warrants is assumed to be equivalent to their remaining contractual term. The dividend rate is based on the historical rate,
which the Company anticipates to remain at zero.
The aforementioned warrant liabilities are not subject to qualified hedge accounting.
There were
no
transfers between Levels 1, 2 or 3 during the quarter ended
 
June 30, 2021.
 
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
At

March 12,

2021

(Initial

Measurement)

Public

Warrants
    
At

March 12,

2021

(Initial

Measurement)

Private

Placement

Warrants
  
                                             
Share price
   
$
9.70
 
  
$
9.70
 
Strike price
   
$
11.50
 
  
$
11.50
 
Term (in years)
   
 
5.0
 
  
 
5.0
 
Volatility
   
 
24.0
% 
  
 
24.0
% 
Risk-free rate
   
 
0.98
% 
  
 
0.98
% 
Dividend yield
   
 
0.0
% 
  
 
0.0
% 
Redemption trigger price
   
$
18.00
 
  
$
0.00
 

     
                  
  
   
At

June 30,

2021

Private

Placement

Warrants
  
                          
Share price
  
$
9.77
 
Strike price
  
$
11.50
 
Term (in years)
  
 
5.0
 
Volatility
  
 
19.2
% 
Risk-free rate
  
 
0.94
% 
Dividend yield
  
 
0.0
% 
Redemption trigger price
  
$
0.00
 
The following table presents the changes in the fair value of warrant liabilities:
 
 
  
Public
 
  
Private
 
  
Warrant
 
  
Placement
 
  
Liabilities
 
Fair value as of November 24, 2020
    $ —        $ —        $ —    
Initial measurement on March 12, 2021
      9,108,000        8,313,333        17,421,333  
Change in valuation inputs or other assumptions
  
 
(264,001
) 
     
(286,666
) 
     
(550,667
)
Fair value as of March 31, 2021
  
$
8,844,000
      $
8,026,667
      $
16,870,667
 
Change in valuation inputs or other assumptions
      (1,782,000 )       (1,720,000 )       (3,502,000 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2021
    $ 7,062,000      $ 6,306,667      $ 13,368,667  
    
 
 
     
 
 
     
 
 
  
XML 25 R16.htm IDEA: XBRL DOCUMENT v3.21.2
Subsequent Events
 6 Months Ended
Jun. 30, 2021
Subsequent Events [Abstract]  
Subsequent Events
Note 10 — Subsequent Events
The Company evaluated subsequent events and transactions that occurred after the balance sheet date through the date that the financial statements were issued. Based upon this review, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements.
XML 26 R17.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies (Policies)
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to
Form 10-Q and
Article 8 of
Regulation S-X of
the U.S. Securities and Exchange Commission (“SEC”). Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented.
The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s prospectus for its IPO as filed with the SEC on March 10, 2021, as well as the Company’s Current Reports on
Form 8-K. The
interim results for the three months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.
Emerging Growth Company Status
Emerging Growth Company Status
The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act of 1933, as amended, (the “Securities Act”), as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.
Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply
to non-emerging growth
companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.
Use of Estimates
Use of Estimates
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.
Cash and Cash Equivalents
Cash and Cash Equivalents
The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents.
 
As of
June 30, 2021 and December 31, 2020, the Company had $529,587 and $25,000 in cash, respectively. The Company had no cash equivalents as of
June 30, 2021 and December 31, 2020.
Marketable Securities Held in Trust Account
Marketable Securities Held in Trust Account
At June 30, 2021, the Trust Account had $330,029,692 held in primarily U.S. Treasury bills. During period January 1, 2021 to June 30, 2021, the Company did not withdraw any of interest income from the Trust Account to pay its tax obligations.
Concentration of Credit Risk
Concentration of Credit Risk
Financial instruments that potentially subject the Company to concentrations of credit risk consist of a cash account in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. At June 30, 2021, the Company has not experienced losses on this account.
Ordinary shares Subject to Possible Redemption
Ordinary shares Subject to Possible Redemption
The Company accounts for its Class A ordinary shares subject to possible redemption in accordance with the guidance in ASC Topic 480 “Distinguishing Liabilities from Equity.” Class A ordinary shares subject to mandatory redemption (if any) are classified as a liability instrument and are measured at fair value. Conditionally redeemable ordinary shares (including ordinary shares that feature redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) are classified as temporary equity. At all other times, ordinary shares are classified as shareholders’ equity. The Company’s ordinary shares feature certain redemption rights that are considered to be outside of the Company’s control and subject to the occurrence of uncertain future events. Accordingly, as of June 30, 2021, 30,263,182 Class A ordinary shares subject to possible redemption are presented at redemption value as temporary equity, outside of the shareholders’ equity section of the Company’s balance sheet.
Net Income (Loss) per Common Share
Net Income (Loss) per Common Share
The Company complies with accounting and disclosure requirements ASC Topic 260, “Earnings Per Share.” The Company’s statements of operations include a presentation of income (loss) per share for Class A ordinary shares subject to possible redemption in a manner similar to
the two-class method
of income (loss) per share. Net income per ordinary shares, basic and diluted for Class A ordinary shares is calculated by dividing the interest income earned on the Trust Account totaling $5,350 for the three months ended June 30, 2021 by the weighted average number of Class A ordinary shares outstanding since original issuance. Net loss per ordinary shares, basic and diluted for Class B ordinary shares is calculated by dividing the net income, adjusted for income attributable to Class A ordinary shares, by the weighted average number of Class B ordinary shares outstanding for the period. Class B ordinary shares includes the Founder Shares as these shares do not have any redemption features and do not participate in the income earned on the Trust Account.
The Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into ordinary shares and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the period presented.
The basic and diluted loss per ordinary share is calculated as follows:
 
 
  
Three Months
Ended
June 30, 2021
 
  
Six Months
Ended
June 30, 2021
 
Redeemable Class A ordinary shares
  
      
  
      
Numerator: Earnings allocable to Redeemable Class A ordinary shares
  
      
  
      
Interest earned on marketable securities held in Trust Account
  
$
24,342
 
  
$
29,692
 
Less: Company portion available to pay taxes
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Net income allocable to shares subject to possible redemption
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Denominator: Weighted Average Redeemable Class A ordinary shares
  
      
  
      
Basic and diluted weighted average shares outstanding
  
 
30,263,182
 
  
 
29,943,752
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
Class A and Class B ordinary shares
  
      
  
      
Numerator: Net Income Minus Net Earnings
  
      
  
      
Net income
  
$
3,133,455
 
  
$
3,168,356
 
Less: Income allocable to ordinary shares subject to possible redemption
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
net income
  
$
3,109,113
 
  
$
3,138,664
 
 
  
 
 
 
  
 
 
 
Weighted average shares outstanding, basic and diluted
  
 
10,986,818
 
  
 
10,268,210
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
0.28
 
  
$
0.31
 
 
  
 
 
 
  
 
 
Offering Costs
Offering Costs
The Company complies with the requirements of the
ASC 340-10-S99-1 and
SEC Staff Accounting Bulletin (“SAB”) Topic 5A—“Expenses of Offering”. Offering costs consist principally of professional and registration fees incurred through the balance sheet date that are related to the Public Offering and that were charged to shareholders’ equity upon the completion of the IPO. Accordingly, on June 30, 2021, offering costs totaling $17,212,069 have been charged to shareholders’ equity (consisting of $6,090,000 of underwriting fee, $10,657,500 of deferred underwriting fee and $464,569 of other offering costs). Of the total transaction cost $475,053 was reclassed to expense as
a non-operating expense
in the statement of operations with the rest of the offering cost charged to shareholders’ equity. The transaction costs were allocated based on the relative fair value basis, compared to the total offering proceeds, between the fair value of the Public Warrant (as defined in Note 3) liabilities and the Class A ordinary shares.
Fair Value of Financial Instruments
Fair Value of Financial Instruments
The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the Financial Accounting Standards Board (“FASB”) ASC 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the balance sheet.
Derivative Warrant Liabilities
Derivative Warrant Liabilities
The Company does not use derivative instruments to hedge exposures to cash flow, market, or foreign currency risks. The Company evaluates all of its financial instruments, including issued share purchase warrants, to determine if such instruments are derivatives or contain features that qualify as embedded derivatives, pursuant to ASC 480 and Accounting Standards
Codification 815-40, Derivatives
and Hedging; Contracts in Entity’s Own Equity (“ASC 815
”), the Company concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the warrants from being accounted for as components of equity. As the warrants meet the definition of a derivative as contemplated in ASC 815, the warrants should be recorded as derivative liabilities on the balance sheet and measured at fair value at each reporting date in accordance with ASC 820, Fair Value Measurement, with changes in fair value recognized in the statement of operations in the period of change.
The Company accounts for its 12,333,333 warrants issued in connection with its IPO (6,600,000) and private placement (5,733,333) as derivative warrant liabilities in accordance with ASC 815. Accordingly, the Company recognizes the warrant instruments as liabilities at fair value and adjusts the instruments to fair value at each reporting period. The liabilities are subject
to re-measurement at
each balance sheet date until exercised or modified, and any change in fair value is recognized in the Company’s statement of operations. The fair value of warrants issued by the Company in connection with the IPO and private placement has been estimated using Monte-Carlo simulations at each measurement date.
Income Taxes
Income Taxes
The Company accounts for income taxes under FASB ASC 740, “Income Taxes” (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.
FASB ASC 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2021. The Company’s management determined that the Cayman Islands is the Company’s only major tax jurisdiction. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. As of June 30, 2021, there were no unrecognized tax benefits and no amounts were accrued for the payment of interest and penalties. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position.
There is currently no taxation imposed on income by the Government of the Cayman Islands. In accordance with Cayman income tax regulations, income taxes are not levied on the Company. Consequently, income taxes are not reflected in the Company’s financial statements. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months.
Recent Accounting Standards
Recent Accounting Standards
Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.
XML 27 R18.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2021
Accounting Policies [Abstract]  
Summary of basic and diluted loss per ordinary shar The basic and diluted loss per ordinary share is calculated as follows:
 
  
Three Months
Ended
June 30, 2021
 
  
Six Months
Ended
June 30, 2021
 
Redeemable Class A ordinary shares
  
      
  
      
Numerator: Earnings allocable to Redeemable Class A ordinary shares
  
      
  
      
Interest earned on marketable securities held in Trust Account
  
$
24,342
 
  
$
29,692
 
Less: Company portion available to pay taxes
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Net income allocable to shares subject to possible redemption
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Denominator: Weighted Average Redeemable Class A ordinary shares
  
      
  
      
Basic and diluted weighted average shares outstanding
  
 
30,263,182
 
  
 
29,943,752
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
—
 
  
$
—
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
Class A and Class B ordinary shares
  
      
  
      
Numerator: Net Income Minus Net Earnings
  
      
  
      
Net income
  
$
3,133,455
 
  
$
3,168,356
 
Less: Income allocable to ordinary shares subject to possible redemption
  
 
24,342
 
  
 
29,692
 
 
  
 
 
 
  
 
 
 
Non-Redeemable
net income
  
$
3,109,113
 
  
$
3,138,664
 
 
  
 
 
 
  
 
 
 
Weighted average shares outstanding, basic and diluted
  
 
10,986,818
 
  
 
10,268,210
 
 
  
 
 
 
  
 
 
 
Basic and diluted net income per ordinary share
  
$
0.28
 
  
$
0.31
 
 
  
 
 
 
  
 
 
XML 28 R19.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements (Tables)
 6 Months Ended
Jun. 30, 2021
Fair Value Disclosures [Abstract]  
Summary of assets measured at fair value on a recurring basis
 
 
  
 
 
  
Quoted
 
  
Significant
 
  
Significant
 
  
 
 
  
Prices In
 
  
Other
 
  
Other
 
  
 
 
  
Active
 
  
Observable
 
  
Unobservable
 
  
June 30,
 
  
Markets
 
  
Inputs
 
  
Inputs
 
  
2021
 
  
(Level 1)
 
  
(Level 2)
 
  
(Level 3)
 
Description
                                    
Warrant liabilities – Public Warrants
      7,062,000        7,062,000        —          —    
Warrant liabilities – Private Warrants
      6,306,667        —          —          6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
     $ 13,368,667      $  7,062,000      $  —        $ 6,306,667  
    
 
 
     
 
 
     
 
 
     
 
 
  
Summary of fair value measurement inputs and valuation techniques
The following table provides quantitative information regarding Level 3 fair value measurements:
 
    
At

March 12,

2021

(Initial

Measurement)

Public

Warrants
    
At

March 12,

2021

(Initial

Measurement)

Private

Placement

Warrants
  
                                             
Share price
   
$
9.70
 
  
$
9.70
 
Strike price
   
$
11.50
 
  
$
11.50
 
Term (in years)
   
 
5.0
 
  
 
5.0
 
Volatility
   
 
24.0
% 
  
 
24.0
% 
Risk-free rate
   
 
0.98
% 
  
 
0.98
% 
Dividend yield
   
 
0.0
% 
  
 
0.0
% 
Redemption trigger price
   
$
18.00
 
  
$
0.00
 

     
                  
  
   
At

June 30,

2021

Private

Placement

Warrants
  
                          
Share price
  
$
9.77
 
Strike price
  
$
11.50
 
Term (in years)
  
 
5.0
 
Volatility
  
 
19.2
% 
Risk-free rate
  
 
0.94
% 
Dividend yield
  
 
0.0
% 
Redemption trigger price
  
$
0.00
 
Summary of fair value of the derivative warrant liabilities
The following table presents the changes in the fair value of warrant liabilities:
 
 
  
Public
 
  
Private
 
  
Warrant
 
  
Placement
 
  
Liabilities
 
Fair value as of November 24, 2020
    $ —        $ —        $ —    
Initial measurement on March 12, 2021
      9,108,000        8,313,333        17,421,333  
Change in valuation inputs or other assumptions
  
 
(264,001
) 
     
(286,666
) 
     
(550,667
)
Fair value as of March 31, 2021
  
$
8,844,000
      $
8,026,667
      $
16,870,667
 
Change in valuation inputs or other assumptions
      (1,782,000 )       (1,720,000 )       (3,502,000 ) 
    
 
 
     
 
 
     
 
 
  
Fair value as of June 30, 2021
    $ 7,062,000      $ 6,306,667      $ 13,368,667  
    
 
 
     
 
 
     
 
 
  
XML 29 R20.htm IDEA: XBRL DOCUMENT v3.21.2
Organization and Business Operations - Additional Information (Detail) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 15, 2021
Mar. 12, 2021
Feb. 04, 2021
Mar. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Proceeds from Issuance Initial Public Offering         $ 323,910,000  
Other offering costs         464,569  
Cash         $ 529,587 $ 25,000
Restricted Investments Term         185 days  
Percentage Of Net asset Held In The Trust Account         80.00%  
Price per share         $ 10.00  
Net tangible assets For Consummation of a Business Combination         $ 5,000,001  
Public share Redeemable percentage         100.00%  
Cash and Cash Equivalents, at Carrying Value         $ 529,587 25,000
Stock issued during the period value for services       $ 8,600,000    
Post Business Combination Target Company [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Business Acquisition, Percentage of Voting Interests Acquired         50.00%  
Common Class B [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during the period value for services         $ 25,000  
Sponsor [Member] | Common Class B [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Stock issued during the period value for services           $ 7,187,500
Sponsor [Member] | Private Placement Warrants [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Warrants issued during the period   5,733,333 5,733,333      
Warrants issued price per share   $ 1.50 $ 1.50      
Debt Conversion, Converted Instrument, Warrants         1,500,000  
Exercise Price of Warrants or Rights     $ 1   $ 1.50  
IPO [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Sale of units, Number of units Issued in Transaction   33,000,000     33,000,000  
Sale of units, price per unit   $ 10.00     $ 10.00  
Proceeds from Issuance Initial Public Offering   $ 330,000,000        
Transaction costs         $ 17,212,069  
Underwriting fees         6,090,000  
Deferred underwriting fees         10,657,500  
Other offering costs         464,569  
Cash         $ 475,053  
IPO [Member] | Common Class A [Member]            
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]            
Payments to Acquire Trust Preferred Investments $ 330,000,000          
XML 30 R21.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies - Additional Information (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Cash $ 529,587   $ 529,587 $ 25,000
Cash Equivalents 0   0 $ 0
FDIC Insured Amount $ 250,000   $ 250,000  
Temporary equity shares outstanding 30,263,182   30,263,182 0
Interest income $ 24,342   $ 29,692  
Offering costs     17,212,069  
Underwriter Fee     6,090,000  
Deferred underwriters discount 10,657,500   10,657,500  
Other offering costs 464,569   464,569  
Offering expenses related to warrant issuance $ 0 $ 475,053 $ 475,053  
Warrants outstanding 12,333,333   12,333,333  
Unrecognized tax benefits $ 0   $ 0  
Unrecognized tax benefits, accrued interest and penalties $ 0   $ 0  
Public Warrants [Member]        
Warrants outstanding 6,600,000   6,600,000  
Private Placement Warrants [Member]        
Warrants outstanding 5,733,333   5,733,333  
Class A Common Stock [Member]        
Temporary equity shares outstanding 30,263,182   30,263,182 0
Interest income $ 5,350      
US Treasury Securities [Member]        
Assets held in trust $ 330,029,692   $ 330,029,692  
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.21.2
Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details) - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Numerator: Earnings allocable to Redeemable Class A ordinary shares      
Less: Company portion available to pay taxes $ 24,342   $ 29,692
Numerator: Net Income Minus Net Earnings      
Net income 3,133,455 $ 34,901 3,168,356
Less: Income allocable to ordinary shares subject to possible redemption 24,342   29,692
Redeemable Common Class A [Member]      
Numerator: Earnings allocable to Redeemable Class A ordinary shares      
Interest earned on marketable securities held in Trust Account $ 24,342   $ 29,692
Denominator: Weighted Average Redeemable Class A ordinary shares      
Basic and diluted weighted average shares outstanding 30,263,182   29,943,752
Basic and diluted net income per ordinary share $ 0   $ 0
Numerator: Net Income Minus Net Earnings      
Weighted average shares outstanding, basic and diluted 30,263,182   29,943,752
Basic and diluted net income per ordinary share $ 0   $ 0
NonRedeemable ClassA and ClassB Shares [Member]      
Denominator: Weighted Average Redeemable Class A ordinary shares      
Basic and diluted weighted average shares outstanding 10,986,818   10,268,210
Basic and diluted net income per ordinary share $ 0.28   $ 0.31
Numerator: Net Income Minus Net Earnings      
Net income $ 3,133,455   $ 3,168,356
Non-Redeemable net income $ 3,109,113   $ 3,138,664
Weighted average shares outstanding, basic and diluted 10,986,818   10,268,210
Basic and diluted net income per ordinary share $ 0.28   $ 0.31
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.21.2
Initial Public Offering - Additional Information (Detail) - $ / shares
 6 Months Ended
Mar. 12, 2021
Jun. 30, 2021
Dec. 31, 2020
Class A Common Stock [Member]      
Common stock par value per share   $ 0.0001 $ 0.0001
IPO [Member]      
Sale of units, Number of units Issued in Transaction 33,000,000 33,000,000  
Sale of units, price per unit $ 10.00 $ 10.00  
Sale of unit, description of transaction   Each Unit consists of one share of Class A ordinary shares, par value $0.0001 per share one-fifth of one redeemable warrant (“Public Warrant”).  
IPO [Member] | Public Warrants [Member]      
Class of warrant exercise price   $ 11.50  
IPO [Member] | Class A Common Stock [Member]      
Common stock par value per share   $ 0.0001  
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.21.2
Private Placement Warrants - Additional Information (Detail) - Sponsor [Member] - Private Placement Warrants [Member] - USD ($)
Mar. 12, 2021
Feb. 04, 2021
Jun. 30, 2021
Class of Warrant or Right [Line Items]      
Warrants issued during the period 5,733,333 5,733,333  
Warrants issued price per share $ 1.50 $ 1.50  
Proceeds from issuance of warrants   $ 8,600,000  
Class of warrant exercise price   $ 1 $ 1.50
Class of warrant exercise price per share   11.50  
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.21.2
Related Party Transactions - Additional Information (Detail) - USD ($)
 3 Months Ended 6 Months Ended 12 Months Ended
Mar. 12, 2021
Feb. 24, 2021
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2021
Dec. 31, 2020
Dec. 17, 2020
Related Party Transaction [Line Items]              
Stock issued during the period value for services       $ 8,600,000      
Temporary equity shares outstanding     30,263,182   30,263,182 0  
Share price     $ 10.00   $ 10.00    
Promissory Note – related party           $ 30,000  
Common Class B [Member]              
Related Party Transaction [Line Items]              
Stock issued during the period value for services         $ 25,000    
Common stock shares outstanding     8,250,000   8,250,000 8,625,000  
Administrative Support Agreement [Member]              
Related Party Transaction [Line Items]              
Expenses from Transactions with Related Party     $ 111,290   $ 111,290    
Sponsor [Member]              
Related Party Transaction [Line Items]              
Lock in period of shareholding     1 year        
Share transfer restriction, threshold consecutive trading days         20 days    
Share transfer restriction, threshold trading days         30 days    
Number of days for a particular event to get over for determning trading period         150 days    
Working capital loans, Convertible amount         $ 1,500,000    
Working capital loans, Conversion price     $ 1.50   $ 1.50    
Working capital Loans     $ 0   $ 0    
Sponsor [Member] | Common Class B [Member]              
Related Party Transaction [Line Items]              
Stock issued during the period value for services           $ 7,187,500  
Stock issued during the period shares issued for shares   1,437,500       25,000  
Common stock shares outstanding 8,250,000 8,625,000          
Temporary equity shares outstanding   1,125,000          
Sponsor forfeiture of shares $ 375,000            
Number of shares no longer subject to forfeiture 750,000            
Sponsor [Member] | Promissory Note [Member]              
Related Party Transaction [Line Items]              
Unsecured promissory note, Face amount             $ 300,000
Promissory Note – related party     $ 0   $ 0    
Sponsor [Member] | Minimum [Member]              
Related Party Transaction [Line Items]              
Share price     $ 12.00   $ 12.00    
Affiliate of Sponsor [Member] | Administrative Support Agreement [Member]              
Related Party Transaction [Line Items]              
Payment of transaction         $ 30,000    
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.21.2
Commitments & Contingencies - Additional Information (Detail) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 31, 2021
Jun. 30, 2021
Commitments and Contingencies Disclosure [Abstract]    
Underwriter discount $ (6,090,000) $ (6,090,000)
Deferred underwriting discount non current   $ 10,657,500
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.21.2
Shareholders' Equity - Additional Information (Detail) - $ / shares
 6 Months Ended
Jun. 30, 2021
Dec. 31, 2020
Class of Stock [Line Items]    
Preferred stock shares authorized 5,000,000 5,000,000
Preferred stock par value per share $ 0.0001 $ 0.0001
Preferred stock shares issued 0 0
Preferred stock shares outstanding 0 0
Temporary equity shares outstanding 30,263,182 0
IPO [Member]    
Class of Stock [Line Items]    
Percentage of number of shares of common stock outstanding 20.00%  
Common Class A [Member]    
Class of Stock [Line Items]    
Common stock shares authorized 500,000,000 500,000,000
Common stock par value per share $ 0.0001 $ 0.0001
Common stock shares issued 2,736,818 0
Common stock shares outstanding 2,736,818 0
Temporary equity shares outstanding 30,263,182 0
Common Class A [Member] | IPO [Member]    
Class of Stock [Line Items]    
Common stock par value per share $ 0.0001  
Common Class B [Member]    
Class of Stock [Line Items]    
Common stock shares authorized 50,000,000 50,000,000
Common stock par value per share $ 0.0001 $ 0.0001
Common stock shares issued 8,250,000 8,625,000
Common stock shares outstanding 8,250,000 8,625,000
Common stock, Conversion basis one-for-one basis  
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.21.2
Warrants - Additional Information (Detail)
 6 Months Ended
Jun. 30, 2021
$ / shares
Class of Warrant or Right [Line Items]  
Share price $ 10.00
Percentage of capital raised for business combination to total equity proceeds 60.00%
Number of consecutive trading days for determining share price 10 days
Share Price Less Than or Equals To USD 9.2 [Member]  
Class of Warrant or Right [Line Items]  
Share price $ 9.20
Class of warrants, exercise price adjustment percentage 115.00%
Share Price Less Than or Equals To USD 18 [Member]  
Class of Warrant or Right [Line Items]  
Share price $ 18.00
Number of consecutive trading days for determining share price 20 days
Class of warrants, exercise price adjustment percentage 180.00%
Class of warrants, redemption notice period 30 days
Number of trading days for determining share price 30 days
Share Price Less Than or Equals To USD 18 [Member] | Class A Common Stock [Member]  
Class of Warrant or Right [Line Items]  
Share price $ 10.00
Number of consecutive trading days for determining share price 20 days
Class of warrants, redemption price per unit $ 0.10
Class of warrants, redemption notice period 30 days
Number of trading days for determining share price 30 days
Share Price More Than or Equals To USD 18 [Member] | Class A Common Stock [Member]  
Class of Warrant or Right [Line Items]  
Share price $ 18.00
Public Warrants [Member]  
Class of Warrant or Right [Line Items]  
Warrants exercisable term from the date of completion of business combination 30 days
Warrants and rights outstanding, term 5 years
Minimum lock in period for SEC registration from date of business combination 15 days
Minimum lock In period to become effective after the closing of the initial Business Combination 60 days
Public Warrants [Member] | Share Price Less Than or Equals To USD 18 [Member]  
Class of Warrant or Right [Line Items]  
Share price $ 18.00
Class of warrants, redemption price per unit 0.01
Public Warrants [Member] | IPO [Member]  
Class of Warrant or Right [Line Items]  
Class of warrant exercise price $ 11.50
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) - Fair Value, Recurring [Member]
Jun. 30, 2021
USD ($)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities $ 13,368,667
Public Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 7,062,000
Private Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 6,306,667
Level 1 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 7,062,000
Level 1 [Member] | Public Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 7,062,000
Level 1 [Member] | Private Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 0
Level 2 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 0
Level 2 [Member] | Public Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 0
Level 2 [Member] | Private Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 0
Level 3 [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 6,306,667
Level 3 [Member] | Public Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities 0
Level 3 [Member] | Private Warrants [Member]  
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]  
Warrant liabilities $ 6,306,667
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) - $ / shares
 6 Months Ended
Mar. 12, 2021
Jun. 30, 2021
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Share Price   $ 10.00
Level 3 [Member] | Measurement Input, Share Price [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Share Price $ 9.70  
Level 3 [Member] | Measurement Input, Share Price [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Share Price 9.70 9.77
Level 3 [Member] | Measurement Input, Exercise Price [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Strike price 11.50  
Level 3 [Member] | Measurement Input, Exercise Price [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Strike price $ 11.50 $ 11.50
Level 3 [Member] | Measurement Input, Expected Term [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Term (in years) 5 years  
Level 3 [Member] | Measurement Input, Expected Term [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Term (in years) 5 years 5 years
Level 3 [Member] | Measurement Input, Price Volatility [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Volatility 24.00%  
Level 3 [Member] | Measurement Input, Price Volatility [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Volatility 24.00% 19.20%
Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Risk-free rate 0.98%  
Level 3 [Member] | Measurement Input, Risk Free Interest Rate [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Risk-free rate 0.98% 0.94%
Level 3 [Member] | Measurement Input, Expected Dividend Rate [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Dividend yield 0.00%  
Level 3 [Member] | Measurement Input, Expected Dividend Rate [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Dividend yield 0.00% 0.00%
Level 3 [Member] | Measurement Input Redemption Trigger Price [Member] | Public Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Redemption trigger price $ 18.00  
Level 3 [Member] | Measurement Input Redemption Trigger Price [Member] | Private Placement Warrants [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Redemption trigger price $ 0.00 $ 0.00
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail) - Fair Value, Recurring [Member] - Level 3 [Member] - USD ($)
 3 Months Ended 4 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance $ 16,870,667
Initial measurement on March 12, 2021   17,421,333
Change in valuation inputs or other assumptions (3,502,000) (550,667)
Ending balance 13,368,667 16,870,667
Public Warrants [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 8,844,000
Initial measurement on March 12, 2021   9,108,000
Change in valuation inputs or other assumptions (1,782,000) (264,001)
Ending balance 7,062,000 8,844,000
Private Placement Warrants [Member]    
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]    
Beginning balance 8,026,667
Initial measurement on March 12, 2021   8,313,333
Change in valuation inputs or other assumptions (1,720,000) (286,666)
Ending balance $ 6,306,667 $ 8,026,667
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.21.2
Fair Value Measurements - Additional Information (Details)
 6 Months Ended
Jun. 30, 2021
USD ($)
Fair Value Disclosures [Abstract]  
Fair value transfer between levels $ 0
EXCEL 42 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 43 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 44 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 45 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 128 258 1 false 36 0 false 6 false false R1.htm 1001 - Document - Cover Page Sheet http://www.claacq.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Condensed Balance Sheets Sheet http://www.claacq.com/role/CondensedBalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://www.claacq.com/role/CondensedBalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 1004 - Statement - Condensed Statements of Operations Sheet http://www.claacq.com/role/CondensedStatementsOfOperations Condensed Statements of Operations Statements 4 false false R5.htm 1005 - Statement - Condensed Statements of Changes in Shareholders' Equity Sheet http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity Condensed Statements of Changes in Shareholders' Equity Statements 5 false false R6.htm 1006 - Statement - Condensed Statement of Cash Flows Sheet http://www.claacq.com/role/CondensedStatementOfCashFlows Condensed Statement of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Organization and Business Operations Sheet http://www.claacq.com/role/OrganizationAndBusinessOperations Organization and Business Operations Notes 7 false false R8.htm 1008 - Disclosure - Significant Accounting Policies Sheet http://www.claacq.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Initial Public Offering Sheet http://www.claacq.com/role/InitialPublicOffering Initial Public Offering Notes 9 false false R10.htm 1010 - Disclosure - Private Placement Warrants Sheet http://www.claacq.com/role/PrivatePlacementWarrants Private Placement Warrants Notes 10 false false R11.htm 1011 - Disclosure - Related Party Transactions Sheet http://www.claacq.com/role/RelatedPartyTransactions Related Party Transactions Notes 11 false false R12.htm 1012 - Disclosure - Commitments & Contingencies Sheet http://www.claacq.com/role/CommitmentsContingencies Commitments & Contingencies Notes 12 false false R13.htm 1013 - Disclosure - Shareholders' Equity Sheet http://www.claacq.com/role/ShareholdersEquity Shareholders' Equity Notes 13 false false R14.htm 1014 - Disclosure - Warrants Sheet http://www.claacq.com/role/Warrants Warrants Notes 14 false false R15.htm 1015 - Disclosure - Fair Value Measurements Sheet http://www.claacq.com/role/FairValueMeasurements Fair Value Measurements Notes 15 false false R16.htm 1016 - Disclosure - Subsequent Events Sheet http://www.claacq.com/role/SubsequentEvents Subsequent Events Notes 16 false false R17.htm 1017 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.claacq.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.claacq.com/role/SignificantAccountingPolicies 17 false false R18.htm 1018 - Disclosure - Significant Accounting Policies (Tables) Sheet http://www.claacq.com/role/SignificantAccountingPoliciesTables Significant Accounting Policies (Tables) Tables http://www.claacq.com/role/SignificantAccountingPolicies 18 false false R19.htm 1019 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.claacq.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.claacq.com/role/FairValueMeasurements 19 false false R20.htm 1020 - Disclosure - Organization and Business Operations - Additional Information (Detail) Sheet http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail Organization and Business Operations - Additional Information (Detail) Details 20 false false R21.htm 1021 - Disclosure - Significant Accounting Policies - Additional Information (Detail) Sheet http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail Significant Accounting Policies - Additional Information (Detail) Details 21 false false R22.htm 1022 - Disclosure - Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details) Sheet http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details) Details 22 false false R23.htm 1023 - Disclosure - Initial Public Offering - Additional Information (Detail) Sheet http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail Initial Public Offering - Additional Information (Detail) Details 23 false false R24.htm 1024 - Disclosure - Private Placement Warrants - Additional Information (Detail) Sheet http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail Private Placement Warrants - Additional Information (Detail) Details 24 false false R25.htm 1025 - Disclosure - Related Party Transactions - Additional Information (Detail) Sheet http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail Related Party Transactions - Additional Information (Detail) Details 25 false false R26.htm 1026 - Disclosure - Commitments & Contingencies - Additional Information (Detail) Sheet http://www.claacq.com/role/CommitmentsContingenciesAdditionalInformationDetail Commitments & Contingencies - Additional Information (Detail) Details 26 false false R27.htm 1027 - Disclosure - Shareholders' Equity - Additional Information (Detail) Sheet http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail Shareholders' Equity - Additional Information (Detail) Details 27 false false R28.htm 1028 - Disclosure - Warrants - Additional Information (Detail) Sheet http://www.claacq.com/role/WarrantsAdditionalInformationDetail Warrants - Additional Information (Detail) Details 28 false false R29.htm 1029 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail) Details 29 false false R30.htm 1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) Sheet http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail) Details 30 false false R31.htm 1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail) Sheet http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail) Details 31 false false R32.htm 1032 - Disclosure - Fair Value Measurements - Additional Information (Details) Sheet http://www.claacq.com/role/FairValueMeasurementsAdditionalInformationDetails Fair Value Measurements - Additional Information (Details) Details 32 false false All Reports Book All Reports d387099d10q.htm claa-20210630.xsd claa-20210630_cal.xml claa-20210630_def.xml claa-20210630_lab.xml claa-20210630_pre.xml d387099dex311.htm d387099dex321.htm http://xbrl.sec.gov/dei/2021 http://fasb.org/srt/2021-01-31 http://fasb.org/us-gaap/2021-01-31 true true JSON 48 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "d387099d10q.htm": { "axisCustom": 1, "axisStandard": 12, "contextCount": 128, "dts": { "calculationLink": { "local": [ "claa-20210630_cal.xml" ] }, "definitionLink": { "local": [ "claa-20210630_def.xml" ] }, "inline": { "local": [ "d387099d10q.htm" ] }, "labelLink": { "local": [ "claa-20210630_lab.xml" ], "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-doc-2021-01-31.xml" ] }, "presentationLink": { "local": [ "claa-20210630_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-ref-2021-01-31.xml" ] }, "schema": { "local": [ "claa-20210630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd", "https://xbrl.sec.gov/country/2021/country-2021.xsd", "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://xbrl.sec.gov/currency/2021/currency-2021.xsd", "https://xbrl.sec.gov/exch/2021/exch-2021.xsd", "https://xbrl.sec.gov/naics/2021/naics-2021.xsd", "https://xbrl.sec.gov/sic/2021/sic-2021.xsd", "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_doc.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://xbrl.fasb.org/us-gaap/2021/elts/us-parts-codification-2021-01-31.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021_ref.xsd" ] } }, "elementCount": 302, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 5, "total": 5 }, "keyCustom": 48, "keyStandard": 210, "memberCustom": 16, "memberStandard": 20, "nsprefix": "claa", "nsuri": "http://www.claacq.com/20210630", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "role": "http://www.claacq.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Private Placement Warrants", "role": "http://www.claacq.com/role/PrivatePlacementWarrants", "shortName": "Private Placement Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:PrivatePlacementTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Related Party Transactions", "role": "http://www.claacq.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Commitments & Contingencies", "role": "http://www.claacq.com/role/CommitmentsContingencies", "shortName": "Commitments & Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Shareholders' Equity", "role": "http://www.claacq.com/role/ShareholdersEquity", "shortName": "Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Warrants", "role": "http://www.claacq.com/role/Warrants", "shortName": "Warrants", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:WarrantsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Fair Value Measurements", "role": "http://www.claacq.com/role/FairValueMeasurements", "shortName": "Fair Value Measurements", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Subsequent Events", "role": "http://www.claacq.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Significant Accounting Policies (Policies)", "role": "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Significant Accounting Policies (Tables)", "role": "http://www.claacq.com/role/SignificantAccountingPoliciesTables", "shortName": "Significant Accounting Policies (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Fair Value Measurements (Tables)", "role": "http://www.claacq.com/role/FairValueMeasurementsTables", "shortName": "Fair Value Measurements (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Condensed Balance Sheets", "role": "http://www.claacq.com/role/CondensedBalanceSheets", "shortName": "Condensed Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromIssuanceInitialPublicOffering", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Organization and Business Operations - Additional Information (Detail)", "role": "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "shortName": "Organization and Business Operations - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "lang": "en-US", "name": "claa:RestrictedInvestmentsTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Significant Accounting Policies - Additional Information (Detail)", "role": "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "shortName": "Significant Accounting Policies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TaxesOther", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1022 - Disclosure - Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details)", "role": "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails", "shortName": "Significant Accounting Policies - Summary of basic and diluted loss per ordinary share (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "ix:continuation", "us-gaap:EarningsPerSharePolicyTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:TaxesOther", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021_CommonClassAMemberusgaapStatementClassOfStockAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1023 - Disclosure - Initial Public Offering - Additional Information (Detail)", "role": "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "shortName": "Initial Public Offering - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "claa:InitialPublicOfferingTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": null, "lang": "en-US", "name": "us-gaap:SaleOfStockDescriptionOfTransaction", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P03_12_2021To03_12_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "INF", "first": true, "lang": null, "name": "claa:ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1024 - Disclosure - Private Placement Warrants - Additional Information (Detail)", "role": "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "shortName": "Private Placement Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "claa:PrivatePlacementTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P02_04_2021To02_04_2021_PrivatePlacementWarrantsMemberusgaapClassOfWarrantOrRightAxis_SponsorMemberusgaapRelatedPartyTransactionsByRelatedPartyAxis", "decimals": "0", "lang": null, "name": "us-gaap:ProceedsFromIssuanceOfWarrants", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueIssuedForServices", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1025 - Disclosure - Related Party Transactions - Additional Information (Detail)", "role": "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "shortName": "Related Party Transactions - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "div", "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P04_01_2021To06_30_2021_AdministrativeSupportAgreementMemberusgaapRelatedPartyTransactionAxis", "decimals": "0", "lang": null, "name": "us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "0", "first": true, "lang": null, "name": "claa:UnderwriterDiscount", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1026 - Disclosure - Commitments & Contingencies - Additional Information (Detail)", "role": "http://www.claacq.com/role/CommitmentsContingenciesAdditionalInformationDetail", "shortName": "Commitments & Contingencies - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "0", "lang": null, "name": "claa:DeferredUnderwritingDiscountNonCurrent", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "us-gaap:PreferredStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1027 - Disclosure - Shareholders' Equity - Additional Information (Detail)", "role": "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "shortName": "Shareholders' Equity - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021_IPOMemberusgaapSubsidiarySaleOfStockAxis", "decimals": "2", "lang": null, "name": "claa:PercentageOfNumberOfSharesOfCommonStockOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1028 - Disclosure - Warrants - Additional Information (Detail)", "role": "http://www.claacq.com/role/WarrantsAdditionalInformationDetail", "shortName": "Warrants - Additional Information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "claa:WarrantsDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "2", "lang": null, "name": "claa:PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds", "reportCount": 1, "unique": true, "unitRef": "Unit_pure", "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1029 - Disclosure - Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail)", "role": "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "shortName": "Fair Value Measurements - Summary of Assets Measured at Fair Value on a Recurring Basis (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:WarrantsAndRightsOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "div", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:TemporaryEquitySharesOutstanding", "reportCount": 1, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Condensed Balance Sheets (Parenthetical)", "role": "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "shortName": "Condensed Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": null }, "R30": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn06_30_2021", "decimals": "2", "first": true, "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1030 - Disclosure - Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail)", "role": "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "shortName": "Fair Value Measurements - Summary of Fair Value Measurement Inputs and Valuation Techniques (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn03_12_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_MeasurementInputSharePriceMemberusgaapMeasurementInputTypeAxis_PublicWarrantsMemberusgaapClassOfWarrantOrRightAxis", "decimals": "2", "lang": null, "name": "us-gaap:SharePrice", "reportCount": 1, "unique": true, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "div", "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn03_31_2021_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1031 - Disclosure - Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail)", "role": "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail", "shortName": "Fair Value Measurements - Summary of Fair Value of the Derivative Warrant Liabilities (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn11_23_2020_FairValueInputsLevel3MemberusgaapFairValueByFairValueHierarchyLevelAxis_FairValueMeasurementsRecurringMemberusgaapFairValueByMeasurementFrequencyAxis", "decimals": null, "lang": null, "name": "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "true" } }, "R32": { "firstAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "claa:FairValueTransferBetweenLevels", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1032 - Disclosure - Fair Value Measurements - Additional Information (Details)", "role": "http://www.claacq.com/role/FairValueMeasurementsAdditionalInformationDetails", "shortName": "Fair Value Measurements - Additional Information (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "us-gaap:FairValueDisclosuresTextBlock", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "claa:FairValueTransferBetweenLevels", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "claa:OperationAndFormationCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Condensed Statements of Operations", "role": "http://www.claacq.com/role/CondensedStatementsOfOperations", "shortName": "Condensed Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P04_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "claa:OperationAndFormationCosts", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "PAsOn12_31_2020", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Condensed Statements of Changes in Shareholders' Equity", "role": "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "shortName": "Condensed Statements of Changes in Shareholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To03_31_2021", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueNewIssues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Condensed Statement of Cash Flows", "role": "http://www.claacq.com/role/CondensedStatementOfCashFlows", "shortName": "Condensed Statement of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidExpense", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Organization and Business Operations", "role": "http://www.claacq.com/role/OrganizationAndBusinessOperations", "shortName": "Organization and Business Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Significant Accounting Policies", "role": "http://www.claacq.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Initial Public Offering", "role": "http://www.claacq.com/role/InitialPublicOffering", "shortName": "Initial Public Offering", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "d387099d10q.htm", "contextRef": "P01_01_2021To06_30_2021", "decimals": null, "first": true, "lang": "en-US", "name": "claa:InitialPublicOfferingTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 36, "tag": { "claa_AdministrativeSupportAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Administrative support agreement.", "label": "Administrative Support Agreement [Member]" } } }, "localname": "AdministrativeSupportAgreementMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_AffiliateOfSponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Affiliate of sponsor.", "label": "Affiliate Of Sponsor [Member]", "terseLabel": "Affiliate of Sponsor [Member]" } } }, "localname": "AffiliateOfSponsorMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change in value of ordinary shares subject to possible redemption.", "label": "Change In Value Of Ordinary Shares Subject To Possible Redemption", "terseLabel": "Change in value of Class\u00a0A ordinary shares subject to possible redemption" } } }, "localname": "ChangeInValueOfOrdinarySharesSubjectToPossibleRedemption", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "claa_ClassAOrdinarySharesSubjectToPossibleRedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Class A Ordinary Shares Subject To Possible Redemption [Member]", "terseLabel": "Class A ordinary shares subject to possible redemption [Member]" } } }, "localname": "ClassAOrdinarySharesSubjectToPossibleRedemptionMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "claa_ClassOfWarrantOrRightsIssuePricePerWarrant": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrant or rights issue price per warrant.", "label": "Class Of Warrant Or Rights Issue Price Per Warrant", "terseLabel": "Warrants issued price per share" } } }, "localname": "ClassOfWarrantOrRightsIssuePricePerWarrant", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "claa_ClassOfWarrantsExercisePriceAdjustmentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants exercise price adjustment percentage.", "label": "Class Of Warrants Exercise Price Adjustment Percentage", "terseLabel": "Class of warrants, exercise price adjustment percentage" } } }, "localname": "ClassOfWarrantsExercisePriceAdjustmentPercentage", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "claa_ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants or rights number of warrants issued during the period.", "label": "Class Of Warrants Or Rights Number Of Warrants Issued During The Period", "terseLabel": "Warrants issued during the period" } } }, "localname": "ClassOfWarrantsOrRightsNumberOfWarrantsIssuedDuringThePeriod", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "claa_ClassOfWarrantsRedemptionNoticePeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants redemption notice period.", "label": "Class Of Warrants Redemption Notice Period", "terseLabel": "Class of warrants, redemption notice period" } } }, "localname": "ClassOfWarrantsRedemptionNoticePeriod", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_ClassOfWarrantsRedemptionPricePerUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class of warrants redemption price per unit.", "label": "Class Of Warrants Redemption Price Per Unit", "terseLabel": "Class of warrants, redemption price per unit" } } }, "localname": "ClassOfWarrantsRedemptionPricePerUnit", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "claa_DeferredOfferingCostsAssociatedWithInitifialPublicOffering": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred offering costs associated with initifial public offering.", "label": "Deferred Offering Costs Associated With Initifial Public Offering", "terseLabel": "Deferred offering costs associated with IPO" } } }, "localname": "DeferredOfferingCostsAssociatedWithInitifialPublicOffering", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "claa_DeferredUnderwriterDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriter discount.", "label": "Deferred Underwriter Discount", "terseLabel": "Deferred underwriter discount" } } }, "localname": "DeferredUnderwriterDiscount", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "claa_DeferredUnderwritersDiscountPayableChargedToAdditionalPaidInCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriters' discount payable charged to additional\u00a0paid-in\u00a0capital.", "label": "Deferred Underwriters Discount Payable Charged To Additional Paid In Capital", "terseLabel": "Deferred underwriters' discount payable charged to additional\u00a0paid-in\u00a0capital" } } }, "localname": "DeferredUnderwritersDiscountPayableChargedToAdditionalPaidInCapital", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "claa_DeferredUnderwritingDiscountNonCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "disclosureGuidance": "Deferred underwriting discount non current", "documentation": "Deferred underwriting discount non current.", "label": "Deferred Underwriting Discount Non Current" } } }, "localname": "DeferredUnderwritingDiscountNonCurrent", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CommitmentsContingenciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_DeferredUnderwritingDiscountNoncurrent": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred underwriters discount noncurrent.", "label": "Deferred Underwriting Discount Noncurrent", "terseLabel": "Deferred underwriters discount", "verboseLabel": "Deferred underwriters' discount" } } }, "localname": "DeferredUnderwritingDiscountNoncurrent", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_DerivativeWarrantLiabilitiesPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative Warrant Liabilities [Policy Text Block].", "label": "Derivative Warrant Liabilities [Policy Text Block]", "terseLabel": "Derivative Warrant Liabilities" } } }, "localname": "DerivativeWarrantLiabilitiesPolicyTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "claa_EmergingGrowthCompanyStatusPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Emerging Growth Company Status [Policy Text Block].", "label": "Emerging Growth Company Status [Policy Text Block]", "terseLabel": "Emerging Growth Company Status" } } }, "localname": "EmergingGrowthCompanyStatusPolicyTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "claa_FairValueTransferBetweenLevels": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value transfer between levels.", "label": "Fair Value Transfer Between Levels", "terseLabel": "Fair value transfer between levels" } } }, "localname": "FairValueTransferBetweenLevels", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsAdditionalInformationDetails" ], "xbrltype": "monetaryItemType" }, "claa_InitialFairValueOfWarrantsAccountedForAsLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial fair value of warrants accounted for as liabilities.", "label": "Initial Fair Value Of Warrants Accounted For As Liabilities", "terseLabel": "Initial fair value of warrants accounted for as liabilities" } } }, "localname": "InitialFairValueOfWarrantsAccountedForAsLiabilities", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "claa_InitialPublicOfferingTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Initial public offering.", "label": "Initial Public Offering [Text Block]", "terseLabel": "Initial Public Offering" } } }, "localname": "InitialPublicOfferingTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/InitialPublicOffering" ], "xbrltype": "textBlockItemType" }, "claa_InitialValueOfOrdinarySharesSubjectToPossibleRedemption": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial value of ordinary shares subject to possible redemption.", "label": "Initial Value Of Ordinary Shares Subject To Possible Redemption", "terseLabel": "Initial value of Class\u00a0A ordinary shares subject to possible redemption" } } }, "localname": "InitialValueOfOrdinarySharesSubjectToPossibleRedemption", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "claa_InitialValueOfWarrantLiabilities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Initial value of warrant liabilities.", "label": "Initial Value Of Warrant Liabilities", "terseLabel": "Initial value of warrant liabilities" } } }, "localname": "InitialValueOfWarrantLiabilities", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "claa_LockInPeriodOfShareholding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Lock in period of shareholding.", "label": "Lock In Period Of Shareholding", "terseLabel": "Lock in period of shareholding" } } }, "localname": "LockInPeriodOfShareholding", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_MeasurementInputRedemptionTriggerPriceMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trigger Price [Member].", "label": "Measurement Input Redemption Trigger Price [Member]", "terseLabel": "Measurement Input Redemption Trigger Price [Member]" } } }, "localname": "MeasurementInputRedemptionTriggerPriceMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "claa_MinimumLockInPeriodForSecRegistrationFromDateOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum lock in period\u00a0for SEC registration from date of business combination.", "label": "Minimum Lock In Period For SEC Registration From Date Of Business Combination", "terseLabel": "Minimum lock in period for SEC registration from date of business combination" } } }, "localname": "MinimumLockInPeriodForSecRegistrationFromDateOfBusinessCombination", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum lock In period\u00a0to become effective after the closing of the initial business combination.", "label": "Minimum Lock In Period To Become Effective After The Closing Of The Initial Business Combination", "terseLabel": "Minimum lock In period\u00a0to become effective after the closing of the initial Business Combination" } } }, "localname": "MinimumLockInPeriodToBecomeEffectiveAfterTheClosingOfTheInitialBusinessCombination", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_NonRedeemableOrdinarySharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Redeemable Ordinary Shares [Member]", "terseLabel": "Non-redeemable ordinary shares [Member]" } } }, "localname": "NonRedeemableOrdinarySharesMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "domainItemType" }, "claa_NonredeemableClassaAndClassbSharesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "NonRedeemable ClassA and ClassB Shares [Member]" } } }, "localname": "NonredeemableClassaAndClassbSharesMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "domainItemType" }, "claa_NumberOfConsecutiveTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of consecutive trading days for determining share price.", "label": "Number Of Consecutive Trading Days For Determining Share Price", "terseLabel": "Number of consecutive trading days for determining share price" } } }, "localname": "NumberOfConsecutiveTradingDaysForDeterminingSharePrice", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_NumberOfDaysForAParticularEventToGetOverToDetermineShareTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of Days for a particular event to get over to determine share trading days.", "label": "Number Of Days For A Particular Event To Get Over To Determine Share Trading Days", "terseLabel": "Number of days for a particular event to get over for determning trading period" } } }, "localname": "NumberOfDaysForAParticularEventToGetOverToDetermineShareTradingDays", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_NumberOfSharesNoLongerSubjectToForfeiture": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares no longer subject to forfeiture.", "label": "Number Of Shares No Longer Subject To Forfeiture", "terseLabel": "Number of shares no longer subject to forfeiture" } } }, "localname": "NumberOfSharesNoLongerSubjectToForfeiture", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "claa_NumberOfTradingDaysForDeterminingSharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of trading days for determining share price..", "label": "Number Of Trading Days For Determining Share Price", "terseLabel": "Number of trading days for determining share price" } } }, "localname": "NumberOfTradingDaysForDeterminingSharePrice", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_OfferingCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Offering costs.", "label": "Offering Costs", "terseLabel": "Offering costs" } } }, "localname": "OfferingCosts", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_OfferingCostsPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Offering Costs [Policy Text Block].", "label": "Offering Costs [Policy Text Block]", "terseLabel": "Offering Costs" } } }, "localname": "OfferingCostsPolicyTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "claa_OfferingExpensesRelatedToWarrantIssuance": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Reclassification of offering cost related to warrant issuance", "documentation": "Offering expenses related to warrant issuance.", "label": "Offering Expenses Related To Warrant Issuance", "negatedLabel": "Offering expenses related to warrant issuance", "terseLabel": "Offering expenses related to warrant issuance", "verboseLabel": "Offering costs allocated to warrants" } } }, "localname": "OfferingExpensesRelatedToWarrantIssuance", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_OperationAndFormationCosts": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Operation and formation costs.", "label": "Operation And Formation Costs", "terseLabel": "Formation and operating costs" } } }, "localname": "OperationAndFormationCosts", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "claa_OtherOfferingCostChargedToShareholdersEquity": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other offering cost charged to shareholders equity.", "label": "Other Offering Cost Charged To Shareholders Equity", "terseLabel": "Other offering cost charged to shareholders' equity" } } }, "localname": "OtherOfferingCostChargedToShareholdersEquity", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "claa_OtherOfferingCosts": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other offering costs.", "label": "Other Offering Costs", "terseLabel": "Other offering costs" } } }, "localname": "OtherOfferingCosts", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_PaymentsForDeferredUnderwritingExpense": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Payments for deferred underwriting expense.", "label": "Payments For Deferred Underwriting Expense", "terseLabel": "Deferred underwriting fees" } } }, "localname": "PaymentsForDeferredUnderwritingExpense", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of capital raised for business combination to total equity proceeds.", "label": "Percentage Of Capital Raised For Business Combination To Total Equity Proceeds", "terseLabel": "Percentage of capital raised for business combination to total equity proceeds" } } }, "localname": "PercentageOfCapitalRaisedForBusinessCombinationToTotalEquityProceeds", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "claa_PercentageOfNetAssetHeldInTheTrustAccount": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of net asset held in the trust account.", "label": "Percentage Of Net asset Held In The Trust Account" } } }, "localname": "PercentageOfNetAssetHeldInTheTrustAccount", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "claa_PercentageOfNumberOfSharesOfCommonStockOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of number of shares of common stock outstanding.", "label": "Percentage Of Number Of Shares Of Common Stock Outstanding", "terseLabel": "Percentage of number of shares of common stock outstanding" } } }, "localname": "PercentageOfNumberOfSharesOfCommonStockOutstanding", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "claa_PostBusinessCombinationTargetCompanyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Post business combination target company.", "label": "Post Business Combination Target Company [Member]", "terseLabel": "Post Business Combination Target Company [Member]" } } }, "localname": "PostBusinessCombinationTargetCompanyMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_PrivatePlacementTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private placement.", "label": "Private Placement Warrants" } } }, "localname": "PrivatePlacementTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/PrivatePlacementWarrants" ], "xbrltype": "textBlockItemType" }, "claa_PrivatePlacementWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Private Placement Warrants [Member]", "terseLabel": "Private Placement Warrants [Member]" } } }, "localname": "PrivatePlacementWarrantsMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_PrivateWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Private warrants.", "label": "Private Warrants [Member]", "terseLabel": "Private Warrants [Member]" } } }, "localname": "PrivateWarrantsMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "claa_PromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note.", "label": "Promissory Note [Member]" } } }, "localname": "PromissoryNoteMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_PublicShareRedeemablePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Public share redeemable percentage.", "label": "Public Share Redeemable Percentage", "terseLabel": "Public share Redeemable percentage" } } }, "localname": "PublicShareRedeemablePercentage", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "claa_PublicWarrantsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Public Warrants [Member]", "terseLabel": "Public Warrants [Member]" } } }, "localname": "PublicWarrantsMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_RedeemableCommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redeemable Common Class A [Member]" } } }, "localname": "RedeemableCommonClassAMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "domainItemType" }, "claa_RestrictedInvestmentsTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted investments term.", "label": "Restricted Investments Term" } } }, "localname": "RestrictedInvestmentsTerm", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionRedemptionTriggerPrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Redemption trigger price.", "label": "Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumption Redemption Trigger Price", "terseLabel": "Redemption trigger price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionRedemptionTriggerPrice", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "perShareItemType" }, "claa_SharePriceLessThanOrEqualsToUsdEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Less Than Or Equals To USD Eighteen [Member]", "terseLabel": "Share Price Less Than or Equals To USD 18 [Member]" } } }, "localname": "SharePriceLessThanOrEqualsToUsdEighteenMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_SharePriceLessThanOrEqualsToUsdNinePointTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Less Than Or Equals To USD Nine Point Two [Member]", "terseLabel": "Share Price Less Than or Equals To USD 9.2 [Member]" } } }, "localname": "SharePriceLessThanOrEqualsToUsdNinePointTwoMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_SharePriceMoreThanOrEqualsToUsdEighteenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price More Than Or Equals To USD Eighteen [Member]", "terseLabel": "Share Price More Than or Equals To USD 18 [Member]" } } }, "localname": "SharePriceMoreThanOrEqualsToUsdEighteenMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_SharePriceRangeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Range [Axis]" } } }, "localname": "SharePriceRangeAxis", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "claa_SharePriceRangeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Price Range [Domain]" } } }, "localname": "SharePriceRangeDomain", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_ShareTransferRestrictionThresholdConsecutiveTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share transfer restriction, threshold consecutive trading days.", "label": "Share Transfer Restriction Threshold Consecutive Trading Days", "terseLabel": "Share transfer restriction, threshold consecutive trading days" } } }, "localname": "ShareTransferRestrictionThresholdConsecutiveTradingDays", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_ShareTransferRestrictionThresholdTradingDays": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share transfer restriction, threshold trading days.", "label": "Share Transfer Restriction Threshold Trading Days", "terseLabel": "Share transfer restriction, threshold trading days" } } }, "localname": "ShareTransferRestrictionThresholdTradingDays", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_SponsorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sponsor.", "label": "Sponsor [Member]" } } }, "localname": "SponsorMember", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "claa_StockIssuanceCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Stock issuance costs.", "label": "Stock Issuance Costs", "terseLabel": "Transaction costs" } } }, "localname": "StockIssuanceCosts", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_UnderwriterDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriter discount.", "label": "Underwriter Discount", "terseLabel": "Underwriter discount" } } }, "localname": "UnderwriterDiscount", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CommitmentsContingenciesAdditionalInformationDetail", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "claa_UnderwriterFee": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Underwriter fee.", "label": "Underwriter Fee" } } }, "localname": "UnderwriterFee", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "claa_WarrantLiabilitiesNoncurrent": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrant liabilities noncurrent.", "label": "Warrant Liabilities Noncurrent", "terseLabel": "Warrant Liabilities" } } }, "localname": "WarrantLiabilitiesNoncurrent", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "claa_WarrantsDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants disclosure.", "label": "Warrants Disclosure [Text Block]", "terseLabel": "Warrants" } } }, "localname": "WarrantsDisclosureTextBlock", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/Warrants" ], "xbrltype": "textBlockItemType" }, "claa_WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrants exercisable term from the date of completion of business combination.", "label": "Warrants Exercisable Term From The Date Of Completion Of Business Combination", "terseLabel": "Warrants exercisable term from the date of completion of business combination" } } }, "localname": "WarrantsExercisableTermFromTheDateOfCompletionOfBusinessCombination", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "claa_WorkingCapitalLoans": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Working capital Loans.", "label": "Working Capital Loans", "terseLabel": "Working capital Loans" } } }, "localname": "WorkingCapitalLoans", "nsuri": "http://www.claacq.com/20210630", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r310" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r311" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r315" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r312" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r308" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "tradingSymbolItemType" }, "srt_MinimumMember": { "auth_ref": [ "r132", "r143", "r178", "r180", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r306", "r307" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r132", "r143", "r167", "r178", "r180", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r306", "r307" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r132", "r143", "r167", "r178", "r180", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r291", "r292", "r306", "r307" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r19" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 8.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r12", "r190", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 16.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r60", "r61", "r62", "r187", "r188", "r189", "r215" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net income to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_Assets": { "auth_ref": [ "r56", "r99", "r101", "r105", "r108", "r117", "r118", "r119", "r121", "r122", "r123", "r124", "r125", "r126", "r128", "r129", "r208", "r212", "r233", "r251", "r253", "r279", "r286" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r4", "r6", "r25", "r56", "r108", "r117", "r118", "r119", "r121", "r122", "r123", "r124", "r125", "r126", "r128", "r129", "r208", "r212", "r233", "r251", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsHeldInTrust": { "auth_ref": [ "r53" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The total amount of cash and securities held by third party trustees pursuant to terms of debt instruments or other agreements as of the date of each statement of financial position presented, which can be used by the trustee only to pay the noncurrent portion of specified obligations.", "label": "Assets Held-in-trust", "terseLabel": "Assets held in trust" } } }, "localname": "AssetsHeldInTrust", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsHeldInTrustNoncurrent": { "auth_ref": [ "r53" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited.", "label": "Assets Held-in-trust, Noncurrent", "terseLabel": "Cash and investment held in trust account" } } }, "localname": "AssetsHeldInTrustNoncurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Basis of Accounting, Policy [Policy Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r177", "r179" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r177", "r179", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r203" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_CapitalUnitsMember": { "auth_ref": [ "r300" ], "lang": { "en-us": { "role": { "documentation": "Type of ownership interest in a corporation. Class of capital units or capital shares.", "label": "Capital Units [Member]" } } }, "localname": "CapitalUnitsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_Cash": { "auth_ref": [ "r17", "r253", "r298", "r299" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash", "terseLabel": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r2", "r17", "r48" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash - Ending", "periodStartLabel": "Cash - Beginning" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease": { "auth_ref": [], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.", "label": "Cash and Cash Equivalents, Period Increase (Decrease)", "totalLabel": "Net Change in Cash" } } }, "localname": "CashAndCashEquivalentsPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r7", "r49" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r17" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash Equivalents, at Carrying Value", "terseLabel": "Cash Equivalents" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "Cash, FDIC Insured Amount", "terseLabel": "FDIC Insured Amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r54", "r56", "r75", "r76", "r77", "r80", "r82", "r86", "r87", "r88", "r108", "r117", "r122", "r123", "r124", "r128", "r129", "r141", "r142", "r146", "r150", "r233", "r313" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/CoverPage", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r165", "r181" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r158" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Class of warrant exercise price", "verboseLabel": "Exercise Price of Warrants or Rights" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of Warrant or Right, Number of Securities Called by Each Warrant or Right", "terseLabel": "Class of warrant exercise price per share" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "terseLabel": "Warrants outstanding" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r165", "r181" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r22", "r115", "r281", "r289" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r112", "r113", "r114", "r116", "r305" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments & Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CommitmentsContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]", "terseLabel": "Class A Common Stock [Member]", "verboseLabel": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CoverPage", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonClassBMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.", "label": "Common Class B [Member]", "verboseLabel": "Common Class B [Member]" } } }, "localname": "CommonClassBMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CoverPage", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockConversionBasis": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Description of basis for conversion of convertible common stock.", "label": "Common Stock, Conversion Basis", "terseLabel": "Common stock, Conversion basis" } } }, "localname": "CommonStockConversionBasis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r60", "r61", "r215" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value per share" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r11", "r157" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r11", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 15.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock value" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r91", "r285" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r50", "r51" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Amount", "terseLabel": "Working capital loans, Convertible amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1": { "auth_ref": [ "r50", "r51" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Converted Instrument, Warrants or Options Issued", "terseLabel": "Debt Conversion, Converted Instrument, Warrants" } } }, "localname": "DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r131", "r134" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Working capital loans, Conversion price" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r130", "r135", "r136", "r240", "r241", "r242" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Unsecured promissory note, Face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r18", "r57", "r120", "r122", "r123", "r127", "r128", "r129", "r246" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 9.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Promissory Note \u2013 related party" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasicAndDiluted": { "auth_ref": [ "r81" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements. Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period. Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Basic and Diluted", "terseLabel": "Basic and diluted net income/loss per share", "verboseLabel": "Basic and diluted net income per ordinary share" } } }, "localname": "EarningsPerShareBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareBasicAndDilutedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Basic and Diluted [Abstract]", "terseLabel": "Denominator: Weighted Average Redeemable Class\u00a0A ordinary shares" } } }, "localname": "EarningsPerShareBasicAndDilutedAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r83", "r84" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Net Income (Loss) per Common Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r29", "r30", "r31", "r60", "r61", "r62", "r64", "r69", "r71", "r85", "r109", "r157", "r164", "r187", "r188", "r189", "r201", "r202", "r215", "r234", "r235", "r236", "r237", "r238", "r239", "r293", "r294", "r295", "r316" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r46", "r137" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "negatedLabel": "Change in fair value of warrant liabilities", "terseLabel": "Change in fair value of warrant liabilities" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Abstract]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]", "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r217", "r218", "r219", "r229" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "auth_ref": [ "r217", "r218", "r219", "r227", "r229" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances.", "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "terseLabel": "Summary of assets measured at fair value on a recurring basis" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "terseLabel": "Summary of fair value measurement inputs and valuation techniques" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r133", "r135", "r136", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r218", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r217", "r218", "r221", "r222", "r230" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r226" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "Fair Value Disclosures [Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurements" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r133", "r168", "r169", "r174", "r176", "r218", "r256" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]", "terseLabel": "Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r133", "r135", "r136", "r168", "r169", "r174", "r176", "r218", "r257" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]", "terseLabel": "Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r133", "r135", "r136", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r218", "r258" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]", "terseLabel": "Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsQuantitativeInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Abstract]" } } }, "localname": "FairValueInputsQuantitativeInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency.", "label": "Measurement Frequency [Domain]" } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues": { "auth_ref": [ "r224" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of issuances of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances", "terseLabel": "Initial measurement on March 12, 2021" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r133", "r135", "r136", "r168", "r169", "r170", "r171", "r172", "r173", "r174", "r176", "r256", "r257", "r258" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.", "label": "Fair Value Hierarchy and NAV [Domain]" } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r226", "r230" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]", "terseLabel": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail", "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss": { "auth_ref": [ "r225" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) recognized in income for derivative asset (liability) after deduction of derivative liability (asset), measured at fair value using unobservable input (level 3) and still held.", "label": "Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss)", "terseLabel": "Change in valuation inputs or other assumptions" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]", "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r223", "r228" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "auth_ref": [ "r223", "r228" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "terseLabel": "Summary of fair value of the derivative warrant liabilities" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs": { "auth_ref": [ "r217", "r228" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as derivative asset (liability) after deduction of derivative liability (asset), measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance" } } }, "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueOfTheDerivativeWarrantLiabilitiesDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r231", "r232" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]", "terseLabel": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IPOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "First sale of stock by a private company to the public.", "label": "IPO [Member]", "terseLabel": "IPO [Member]" } } }, "localname": "IPOMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r28", "r193", "r194", "r197", "r198", "r199", "r200" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "auth_ref": [ "r45" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.", "label": "Increase (Decrease) in Accounts Payable", "terseLabel": "Accounts payable" } } }, "localname": "IncreaseDecreaseInAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in current assets and current liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r45" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid assets" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeInterest": { "auth_ref": [ "r34", "r98" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 }, "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_OtherNonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.", "label": "Investment Income, Interest", "negatedLabel": "Interest earned on trust account", "terseLabel": "Interest income" } } }, "localname": "InvestmentIncomeInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_InvestmentIncomeNonoperating": { "auth_ref": [ "r35" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income from investments (for example, dividends) not considered a component of the entity's core operations.", "label": "Investment Income, Nonoperating", "terseLabel": "Interest earned on marketable securities held in Trust Account" } } }, "localname": "InvestmentIncomeNonoperating", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r20", "r56", "r102", "r108", "r117", "r118", "r119", "r122", "r123", "r124", "r125", "r126", "r128", "r129", "r209", "r212", "r213", "r233", "r251", "r252" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r16", "r56", "r108", "r233", "r253", "r280", "r288" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and shareholders' equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Shareholders' Equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r21", "r56", "r108", "r117", "r118", "r119", "r122", "r123", "r124", "r125", "r126", "r128", "r129", "r209", "r212", "r213", "r233", "r251", "r252", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_MarketableSecuritiesPolicy": { "auth_ref": [ "r284" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for investment classified as marketable security.", "label": "Marketable Securities, Policy [Policy Text Block]", "terseLabel": "Marketable Securities Held in Trust Account" } } }, "localname": "MarketableSecuritiesPolicy", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_MeasurementInputExercisePriceMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using agreed upon price for exchange of underlying asset.", "label": "Measurement Input, Exercise Price [Member]", "terseLabel": "Measurement Input, Exercise Price [Member]" } } }, "localname": "MeasurementInputExercisePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]", "terseLabel": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]", "terseLabel": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]", "terseLabel": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]", "terseLabel": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputSharePriceMember": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using share price of saleable stock.", "label": "Measurement Input, Share Price [Member]", "terseLabel": "Measurement Input, Share Price [Member]" } } }, "localname": "MeasurementInputSharePriceMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r220" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Domain]" } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "domainItemType" }, "us-gaap_MinimumNetWorthRequiredForCompliance": { "auth_ref": [ "r301", "r302", "r303", "r304" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of minimum net worth required for mortgage banking as defined by regulatory framework.", "label": "Minimum Net Worth Required for Compliance", "terseLabel": "Net tangible assets For Consummation of a Business Combination" } } }, "localname": "MinimumNetWorthRequiredForCompliance", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Numerator: Net Income Minus Net Earnings" } } }, "localname": "MinorityInterestInNetIncomeLossOfConsolidatedEntitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r42" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash provided by financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows from Financing Activities:" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r42" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash used in investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows from Investing Activities:" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r42", "r44", "r47" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_CashAndCashEquivalentsPeriodIncreaseDecrease", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows from Operating Activities:" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r1", "r26", "r27", "r31", "r32", "r47", "r56", "r63", "r65", "r66", "r67", "r68", "r70", "r71", "r78", "r99", "r100", "r103", "r104", "r106", "r108", "r117", "r118", "r119", "r122", "r123", "r124", "r125", "r126", "r128", "r129", "r216", "r233", "r282", "r290" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net income", "totalLabel": "Net income" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Income (Loss) Attributable to Parent [Abstract]", "terseLabel": "Numerator: Earnings allocable to Redeemable Class\u00a0A ordinary shares" } } }, "localname": "NetIncomeLossAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest": { "auth_ref": [ "r33" ], "crdr": "debit", "lang": { "en-us": { "role": { "definitionGuidance": "Less: Income allocable to ordinary shares subject to possible redemption", "documentation": "Amount of Net Income (Loss) attributable to redeemable noncontrolling interest.", "label": "Net Income (Loss) Attributable to Redeemable Noncontrolling Interest" } } }, "localname": "NetIncomeLossAttributableToRedeemableNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "auth_ref": [ "r65", "r66", "r67", "r68", "r73", "r74", "r79", "r82", "r99", "r100", "r103", "r104", "r106" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Basic", "terseLabel": "Non-Redeemable net income" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Noncash Investing and Financing Items [Abstract]", "terseLabel": "Supplemental Disclosure of\u00a0Non-cash\u00a0Financing Activities:" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r99", "r100", "r103", "r104", "r106" ], "calculation": { "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Loss from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "auth_ref": [ "r59", "r72", "r97", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.", "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "terseLabel": "Organization and Business Operations" } } }, "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncomeExpense": { "auth_ref": [ "r36" ], "calculation": { "http://www.claacq.com/role/CondensedStatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.", "label": "Other Nonoperating Income (Expense)", "totalLabel": "Total other income" } } }, "localname": "OtherNonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other Income (Loss)" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_PaymentsForUnderwritingExpense": { "auth_ref": [ "r43" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash paid for expenses incurred during underwriting activities (the process to review insurance applications, evaluate risks, accept or reject applications, and determine the premiums to be charged) for insurance companies.", "label": "Payments for Underwriting Expense", "terseLabel": "Underwriting fees" } } }, "localname": "PaymentsForUnderwritingExpense", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfStockIssuanceCosts": { "auth_ref": [ "r41" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.", "label": "Payments of Stock Issuance Costs", "negatedLabel": "Payments of offering costs" } } }, "localname": "PaymentsOfStockIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireInvestments": { "auth_ref": [ "r37" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.", "label": "Payments to Acquire Investments", "negatedLabel": "Investment of cash into trust account" } } }, "localname": "PaymentsToAcquireInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireTrustPreferredInvestments": { "auth_ref": [ "r37" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the purchase of trust preferred securities, which possess characteristics of both equity and debt securities.", "label": "Payments to Acquire Trust Preferred Investments" } } }, "localname": "PaymentsToAcquireTrustPreferredInvestments", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r10", "r141" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock par value per share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r10", "r141" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r10", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 14.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r3", "r5", "r110", "r111" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r38" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from Issuance Initial Public Offering", "terseLabel": "Proceeds from Initial Public Offering, net of underwriters' discount" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfPrivatePlacement": { "auth_ref": [ "r38" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement.", "label": "Proceeds from Issuance of Private Placement", "terseLabel": "Proceeds from issuance of Private Placement Warrants" } } }, "localname": "ProceedsFromIssuanceOfPrivatePlacement", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r38" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRelatedPartyDebt": { "auth_ref": [ "r39" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a long-term borrowing made from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Proceeds from Advances from Affiliates.", "label": "Proceeds from Related Party Debt", "terseLabel": "Proceeds from issuance of promissory note to related party" } } }, "localname": "ProceedsFromRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r175", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "auth_ref": [ "r245", "r248" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transactions with related party during the financial reporting period.", "label": "Related Party Transaction, Amounts of Transaction", "terseLabel": "Payment of transaction" } } }, "localname": "RelatedPartyTransactionAmountsOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r175", "r245", "r246", "r248" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r175" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": { "auth_ref": [ "r245" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.", "label": "Related Party Transaction, Expenses from Transactions with Related Party", "terseLabel": "Expenses from Transactions with Related Party" } } }, "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyTransactionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Related Party Transaction [Line Items]" } } }, "localname": "RelatedPartyTransactionLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r175", "r245", "r248", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/PrivatePlacementWarrantsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r243", "r244", "r246", "r249", "r250" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r40" ], "calculation": { "http://www.claacq.com/role/CondensedStatementOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Repayments of Related Party Debt", "negatedLabel": "Repayment of promissory note to related party" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash and Cash Equivalents [Domain]" } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r13", "r164", "r190", "r253", "r287", "r296", "r297" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 17.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated earnings (deficit)" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r60", "r61", "r62", "r64", "r69", "r71", "r109", "r187", "r188", "r189", "r201", "r202", "r215", "r293", "r295" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Earnings (Deficit) [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockDescriptionOfTransaction": { "auth_ref": [ "r207", "r210", "r211" ], "lang": { "en-us": { "role": { "documentation": "Description of stock transaction which may include details of the offering (IPO, private placement), a description of the stock sold, percentage of subsidiary's or equity investee's stock sold, a description of the investors and whether the stock was issued in a business combination.", "label": "Sale of Stock, Description of Transaction", "terseLabel": "Sale of unit, description of transaction" } } }, "localname": "SaleOfStockDescriptionOfTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of Stock, Number of Shares Issued in Transaction", "terseLabel": "Sale of units, Number of units Issued in Transaction" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Sale of units, price per unit" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r206" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r82" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Summary of basic and diluted loss per ordinary shar" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": { "auth_ref": [ "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Schedule of Related Party Transactions, by Related Party [Table]" } } }, "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r23", "r54", "r86", "r87", "r138", "r139", "r140", "r141", "r142", "r143", "r144", "r146", "r150", "r155", "r158", "r159", "r160", "r161", "r162", "r163", "r164" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Strike price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "auth_ref": [ "r184" ], "lang": { "en-us": { "role": { "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "terseLabel": "Dividend yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r183" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "terseLabel": "Volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r185" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Risk-free rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "presentationGuidance": "Price per share", "terseLabel": "Share price", "verboseLabel": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r182", "r191" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Term (in years)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfFairValueMeasurementInputsAndValuationTechniquesDetail" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Ending balance, Shares", "periodStartLabel": "Beginning balance, Shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognition of changes in redemption value of mandatorily redeemable shares. Provides the period over which changes in redemption value are accreted, usually from the issuance date (or from the date that it becomes probable that the security will become redeemable, if later) to the earliest redemption date of the security.", "label": "Shares Subject to Mandatory Redemption, Changes in Redemption Value, Policy [Policy Text Block]", "terseLabel": "Ordinary shares Subject to Possible Redemption" } } }, "localname": "SharesSubjectToMandatoryRedemptionChangesInRedemptionValuePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r52", "r59" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r9", "r10", "r11", "r54", "r56", "r75", "r76", "r77", "r80", "r82", "r86", "r87", "r88", "r108", "r117", "r122", "r123", "r124", "r128", "r129", "r141", "r142", "r146", "r150", "r157", "r233", "r313" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/CoverPage", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r24", "r29", "r30", "r31", "r60", "r61", "r62", "r64", "r69", "r71", "r85", "r109", "r157", "r164", "r187", "r188", "r189", "r201", "r202", "r215", "r234", "r235", "r236", "r237", "r238", "r239", "r293", "r294", "r295", "r316" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r60", "r61", "r62", "r85", "r266" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/CondensedStatementOfCashFlows", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Stock issued during the period shares issued for shares" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r10", "r11", "r157", "r164" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Sale of Units in Initial Public Offering, net of underwriter fee, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationForfeited": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares (or other type of equity) forfeited during the period.", "label": "Shares Issued, Shares, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Sponsor forfeiture of shares, Shares" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "presentationGuidance": "Stock issued during the period value for services", "terseLabel": "Sale of private placement", "verboseLabel": "Stock issued during the period value for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r10", "r11", "r157", "r164" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Sale of Units in Initial Public Offering, net of underwriter fee" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensationForfeited": { "auth_ref": [ "r186" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Value of forfeited shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-based Payment Arrangement, Forfeited", "negatedLabel": "Sponsor forfeiture of shares", "terseLabel": "Sponsor forfeiture of shares" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensationForfeited", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodShares": { "auth_ref": [ "r157" ], "lang": { "en-us": { "role": { "documentation": "Number of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Shares", "terseLabel": "Class A ordinary shares subject to possible redemption, Shares" } } }, "localname": "StockRedeemedOrCalledDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRedeemedOrCalledDuringPeriodValue": { "auth_ref": [ "r157" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock bought back by the entity at the exercise price or redemption price.", "label": "Stock Redeemed or Called During Period, Value", "terseLabel": "Class A ordinary shares subject to possible redemption" } } }, "localname": "StockRedeemedOrCalledDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r11", "r14", "r15", "r56", "r107", "r108", "r233", "r253" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 13.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Ending balance", "periodStartLabel": "Beginning balance", "totalLabel": "Total shareholders' equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets", "http://www.claacq.com/role/CondensedStatementsOfChangesInShareholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Shareholders' equity:" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r55", "r142", "r145", "r146", "r147", "r148", "r149", "r150", "r151", "r152", "r153", "r154", "r156", "r164", "r166" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Shareholders' Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/ShareholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r254", "r255" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/InitialPublicOfferingAdditionalInformationDetail", "http://www.claacq.com/role/OrganizationAndBusinessOperationsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_TaxesOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense classified as other.", "label": "Taxes, Other", "terseLabel": "Less: Company portion available to pay taxes" } } }, "localname": "TaxesOther", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r117", "r122", "r123", "r124", "r128", "r129" ], "calculation": { "http://www.claacq.com/role/CondensedBalanceSheets": { "order": 12.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Class A ordinary shares subject to possible redemption 30,263,182 shares at redemption value" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding", "terseLabel": "Temporary equity shares outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedBalanceSheetsParenthetical", "http://www.claacq.com/role/RelatedPartyTransactionsAdditionalInformationDetail", "http://www.claacq.com/role/ShareholdersEquityAdditionalInformationDetail", "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_USTreasurySecuritiesMember": { "auth_ref": [ "r58", "r168", "r176", "r283" ], "lang": { "en-us": { "role": { "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).", "label": "US Treasury Securities [Member]", "terseLabel": "US Treasury Securities [Member]" } } }, "localname": "USTreasurySecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_UnrecognizedTaxBenefits": { "auth_ref": [ "r192", "r196" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrecognized tax benefits.", "label": "Unrecognized Tax Benefits", "terseLabel": "Unrecognized tax benefits" } } }, "localname": "UnrecognizedTaxBenefits", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued": { "auth_ref": [ "r195" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of statutory penalties accrued for a tax position claimed or expected to be claimed by the entity, in its tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties Accrued", "terseLabel": "Unrecognized tax benefits, accrued interest and penalties" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAccrued", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r89", "r90", "r92", "r93", "r94", "r95", "r96" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CoverPage" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsNoteDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Warrants and Rights Note Disclosure [Abstract]" } } }, "localname": "WarrantsAndRightsNoteDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "xbrltype": "stringItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Warrants and Rights Outstanding", "terseLabel": "Warrant liabilities" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/FairValueMeasurementsSummaryOfAssetsMeasuredAtFairValueOnARecurringBasisDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrants and rights outstanding, term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/WarrantsAdditionalInformationDetail" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "disclosureGuidance": "Weighted average shares outstanding, basic and diluted", "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).", "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted", "terseLabel": "Basic and diluted weighted average shares outstanding", "verboseLabel": "Weighted average shares outstanding" } } }, "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted", "nsuri": "http://fasb.org/us-gaap/2021-01-31", "presentation": [ "http://www.claacq.com/role/CondensedStatementsOfOperations", "http://www.claacq.com/role/SignificantAccountingPoliciesSummaryOfBasicAndDilutedLossPerOrdinaryShareDetails" ], "xbrltype": "sharesItemType" } }, "unitCount": 6 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r114": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "http://asc.fasb.org/topic&trid=2144648" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349" }, "r116": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "http://asc.fasb.org/topic&trid=2127136" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r166": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "http://asc.fasb.org/topic&trid=2208762" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.1)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "c(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(g)(2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2)", "Topic": "718", "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "10B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "15A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "http://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569655-111683" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "http://asc.fasb.org/topic&trid=2197479" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "2C", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL7498348-110258" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.28,29)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.9)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r250": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "http://asc.fasb.org/topic&trid=2122745" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r255": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "http://asc.fasb.org/topic&trid=2122774" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61929-109447" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62059-109447" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62395-109447" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e62479-109447" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=SL6807758-109447" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "http://asc.fasb.org/extlink&oid=123377692&loc=d3e61872-109447" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Subparagraph": "(b)", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "320", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62652-112803" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.16)", "Topic": "946", "URI": "http://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47080-110998" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "948", "URI": "http://asc.fasb.org/extlink&oid=6490092&loc=d3e47304-110998" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691" }, "r308": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r309": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r310": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r311": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r312": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r313": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r314": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r315": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.19)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7(b))", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(b))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))", "Topic": "235", "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r59": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "http://asc.fasb.org/topic&trid=2122369" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r72": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "250", "URI": "http://asc.fasb.org/topic&trid=2122394" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r97": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "http://asc.fasb.org/topic&trid=2134479" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599" } }, "version": "2.1" } ZIP 49 0001193125-21-254146-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-21-254146-xbrl.zip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�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

:[=C\_W[ZQ7R[QINX*WXU#8/;]"M\?Q_TN6OJFLWZ\!P0!]?U/K<- M^-^_L]CSB5CPF__(N[^>/!1+/^ _I(*.4[SX42G2[R>?NLSR^"\?$H^<_H9; M1P_H!::G,^L!OG6,._C,6_!MOY<7?M4-"03YIG]SYC9LXQ8$T()O.CTME8$ M%GY=PP9L#V_@C2ZSFK;!W_Z'#Q=\5Q%$?JUR>5FY6O)U=<-PN>>U?=A7RWUP MG1>31+^)(IF07:X6:Y5RZ6+!E=Q]G5C!AR3AN+S+4=!R[],OR&W7'NDI>*Q& MVNW:!WK]]<0S^P,+V9 ^Z[GX5E3(IZ$J/GOS0!5\D \)^7;IQ_P M7(&/!I> M@LIFAGP@702W>( GXO6OHQ>'CY J:[82AX6.X#V/BCO[TG,"EO\@0 MOY92E23N-*FJ?=+DU9RD=O2G:> '79.[&DE1GFJGW#3_)ZDBQF^&YWU(??Z M]&OT)S@&KH\J\%-HS!5+X9VC[T9K-6+77IQ6BJ.W&/+*#V/O^9 2BJ,ZE[+ MSB!LA-ODI^PV_&;EW9;*/RI$%<4L[K88VCD;V&WQ/%?T?[X/^D_(B(JDC.S" M:!D948G1T?HR(GNP2X')TE[Q'CO$-TW[^ MQOM/W T\C A$5WX>QJZ]<\&!Q$A(_^\A=N5:809?3K M%T Z&'F](5U.=*FH_-BI?)5%S:"HM'5-TFC.F6XSS.*:+Z":CXE;TG:<,W;) M!7W&&*ZT?Z6@Z#R'=+Y;M5 Z-+8K*[93;)=YMBL?&MMEP 52;*?83CE!"[)+ MIBE?N149=BL4Y2A#_2 ,=47(RO0]"--7$;(R)@_"M%!I+.7!*3-(,9UBNFPQ M7:Y-MN9#*T[3[>#),PV3N<,VLWBKV_8=_:_,T_2L58?71!O-)YYNG'[?L8EY MZPF$X=D.7*[DZVCK"K.K"(2IX(R];Q(5^22I10GDX%3@KHEJPRHWRS3UO=UQ M26,/VZBL33R/D2 8YO7JMH'_-/ <(\ ?=IQYBIFY[/"BZ7O/)RZ75CF91N$Q M2?9#$]A')$!EUOK!8CI1ZS$A<>;6\XG.F$3Y?'0R]'.>,=?N,9<#2>K\*_>\ M3H_9+1=T/[.\CO/=,^Y-FS\XINUW7AVQGYNO]?KHID=F/_/,(I3X+7VQ8U\M MN/F#Q'$#)13G]M'A-[GQ?.)V!1OH<.EA7\%?181C_)K-T%N)NJ6T("HS#8@T* P!?Q\D;_TY@()]$]. Z?=,# WO M'9\O0#&*P+9$8'-6D(SN3"(MG^2G"&EI0LHR.C=5M!JK5*$GQ..N;GJ*VU;CMA3P*88[ M"(9[<#S_<^"9-O<\<"&?3)N:;':8^\Q]^&# [&&F9,1LNNP0_ M?,.R6?VVL'3GUSW.P[8/9[Y9/%';O#^ %7?89,$ M:=25('),)'/OV+A]WF< B"2.0^,VUN-)AKF_9SNKHZ6#)(W_TQX5]%JG:4=K2K'JP>=],I5L5^RKV5:W\%/GGEOQ'8<+C2:J0EIBU\6,B@'O'=D>@ M0" P; ""OSP=4[Q\(2 <$V'4C;YIFY[O,M]\X>U@,'!BW5\B>C5K:<7JMG);*B]/KZ-IMT.OV M#K8-N XH[G"W'W_<]'-M*A6Y$9)?Z13=.*Z.+'ZK&/*H#IKN/^&HF%0Q:1J3 MTCGF_W7 .#(M (U2G-E6G*GH4FRIV%*ISZRI3\6JQ\&JCZ;WUYW+X;$^=[GG M/S)_P;XJ2HWNBS>GXTPQJ&)0I5 SJ5 5TQX1TX;!AUOS!4G>4%HU^UIU.LX4 M@RH&55HUDUI5,6T&F5;-HSUD[*HVA%F5GQD_7IXE(MZ:MQYUG.JXYO,S=Y=H M5*Q,_VU;$?3:95"FC C%HTK!K2%$3)9%O_'Q5;*Y,I2N%6Q6HY8;85924J)[2^1L8W)3(JY M,L1<2I5E294IAML.PZGD7T;QA#BJQN*LU54;VB@,;S\DLZ,^;$!$9=F5[[MM^@%[E#WXRCVOTV-VRVW\'3#+ZSC? M/:.!82/.I:5S\[5>']WPR.QGGED2$$G\U,6.?;7 QH^)(I8//B@:6H^&E)&R M.7&F*ICV4TB>)2+82)/X'_5NU[1,^!KX3%'5J/G\%+!L0+SEI/5]EDA]C@:Z M-VW^X)BVWWEUCD[]3F[^F"A#U8T<&<)5T\VMTV!66E[NO[@CRS45Q\BDJKM? M1GOK*595K*J:A^6L=9=B6L6TJC=1SCH#*:;-*],N?5 YTWR1C8.^6<:W:B.1 M#3&]CR8.2DKGE6O54/8]#&7/$@&HH>P9&LJ>)<)0W0>SVG1F:]KV\(AX(T4C M>21'55Z!1%'^43P/B2+Z74FVS%KQ&2^'*Y\6SQX?90T18[3JDLI\L755O"3)%B!J.5Q25L@.)IJ7Q:*6W*!BC'; #YNZ)7 M1:\+J/OR$NJ^O%%UK^A4T>FBFKV\&2:?%9 MYRL4]6V/^A9P]=.0MD7R(T5=NMP(^95*4N@5J6N2,"PWEU:,OHNEQKQ'K@>N M:]K/4QX8N_;.Y7\'W-:'JG_C=M)VTV"=EK.;@<-CRB4"^Y66L%$JF[*I\\6J M!UL$L/]XG6)?Q;[;9=],,Z B_SR2/WG8M1_EBNIXM:V"EZ2'6CLM5S;FH:9C M3E68Y@!S(U6S?#<:<0?]G7I#X^\ =@57@<^-@_AV M22TNWK=$:@L&4(^=U.9*%D5JZ:16-PP3 W+,>F"FT;1E#[H#(Z(YN)P)A'SB M]9'[S+2YT6"N#99Z>D'LP2(T??=YPN0Z7?".71DE=VQ:[MC6YC,9&A=9<949BP[J8$M,N):9M*C-.:8^],]T6:R(RRG3*C%-FG&+$O3-BIEE) M$?+>"#FP34'%.)?WQ_?V;8Q0^@*^GTS/.2^7+J_AV_ IX5?18_$YZ<_TJ%MC MRF/ESNGK%9X[@.NF/A6_7.&9MVR8\LC =Z_AFQ6>]V_.W"D/Q*]6>"+@X >@ M5 RDBSW:H%;OT9]XTWW0!VKU'7=EA$X^ 3^]Y;;3-^W4)R^,T^1#/HQM(@&& M#^;;-3S."5R=>^+/'F<&L,\O'^".3[_@#PU_:IX_M$!^=8'&3SWS/_Q:*U7. MRK7!VT>MS]QGTS[UG<&U5ASXT0=/CN\[?;CP[.*2]S]^I'M?.2KS:^W)L8R/ M)Y]^85K/Y=U?3_[A._K)IP[V)-6XMW1&EVQ&A;X3O097B _&GNH9=K\M"=W M4(IM=>K>Z;,GQP68RL].=<=RW&O-?7YZ5RQH^-_[\4ODXDL(W>0WM)!KS7,L MD\ 77QSW 0ZGWH#I(*SQU7"W7-C;QX^&Z0TL-@0QAKN >__['Z6+XD>)Z$D0 M)_9:662OY=SN-86<-*+6+NN;UO!:^^^_ \?_V %5YFGW_%5[=/K,%A_**R5/ MU,8!=3Z%*)+[B;,&<<;$#B:N7FUIRP+N^WVST[C5VIUZI]'6X@#<+1BG\59. MP-ANW'Q_;':: ,/Z_:W6^-?-E_K]/QO:3>O;MV:[W6S=[PZVY>S"MKP*;/]@ M7@\N]!V[H-V>W9QIY6+U_&H>/#<%D756OKQ4&M-'8HFT-M)70@1+B5HN_9Q4 M?"'9)"3[Q7I">^+F+0OMG0J=!&%LBC->>Z;/"0CP3MMY==E@>O;QT]0,<'IV6<:-(W>413:TK_Z)-/I>+I[V0$CAZ8 M!+SBH\/EH]5XIK@3GEEC;$)_RW?0WW+A J?T+@VC*$ Y1!5KZ6Y)*/ @BPT\^#C\+?HJL=N/@LA* MQ>+/2/>X!3=\!<0(TU?.38HWTQ&0707YQ<=)^>4;8WM9< -398AP(+=L?"6EBXV[MO)BD?W^O?[8:3Q^_;?V MV'AH/7:TA^^/[>_U^X[6:6E@"G?0WBU5M-:C5JJ^,]YKK3NM\Z6AQ:SDR$*N MWW3PZ])5Y3S5I"/TPD^*=1!O)A&G X6X&&[P>PCGMPBDN/23[5K:!R<<[QQ7 M\WM<^SMD74W$0#5N&]S0YK+\ UW=$ UM5F!X ^LVX::>P89#P"NW3S[]%MA< MJX!VG?OV.],#KL?HX!U\XBUH%.'/2:&2_#NGSH;29IO39M2CE,J_UU5G769Y MH3X[5_HL _JL\UB_;S=):RF%MAV%%FH6/V*C4+5T7:<_N1V#ZPZ.^'%@3P$H M'Y>>LZ)0W/U/B27P- ]T9SN(8VZ/&/%0ENEASEK;?.3&M+B U+US-B>$TZ!, M-=X!WSUQ=T&+I5@LG9X72[5S%YK>(RN0_9)">;9F:]K@5PRD:T$GH&^

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end